Human	O
T-cell	O
leukemia	O
virus	O
type	O
I	O
Tax	B-protein
associates	O
with	O
and	O
is	O
negatively	O
regulated	O
by	O
the	O
NF-kappa	B-protein
B2	I-protein
p100	I-protein
gene	I-protein
product	I-protein
:	O
implications	O
for	O
viral	O
latency	O
.	O

Human	O
T-cell	O
leukemia	O
virus	O
type	O
I	O
(	O
HTLV-I	O
)	O
is	O
the	O
etiologic	O
agent	O
of	O
the	O
adult	O
T-cell	O
leukemia	O
,	O
an	O
aggressive	O
and	O
often	O
fatal	O
malignancy	O
of	O
activated	B-cell_line
human	I-cell_line
CD4	I-cell_line
T	I-cell_line
cells	I-cell_line
.	O

HTLV-I	O
encodes	O
an	O
essential	O
40-kDa	B-protein
protein	I-protein
termed	O
Tax	B-protein
that	O
not	O
only	O
transactivates	O
the	O
long	O
terminal	O
repeat	O
of	O
this	O
retrovirus	O
but	O
also	O
induces	O
an	O
array	O
of	O
cellular	B-DNA
genes	I-DNA
.	O

Tax	B-protein
-mediated	O
transformation	O
of	O
T	B-cell_type
cells	I-cell_type
likely	O
involves	O
the	O
deregulated	O
expression	O
of	O
various	O
cellular	B-DNA
genes	I-DNA
that	O
normally	O
regulate	O
lymphocyte	B-cell_type
growth	O
produced	O
by	O
altered	O
activity	O
of	O
various	O
endogenous	O
host	O
transcription	B-protein
factors	I-protein
.	O

In	O
particular	O
,	O
Tax	B-protein
is	O
capable	O
of	O
modulating	O
the	O
expression	O
or	O
activity	O
of	O
various	O
host	O
transcription	B-protein
factors	I-protein
,	O
including	O
members	O
of	O
the	O
NF-kappa	B-protein
B/Rel	I-protein
and	O
CREB/ATF	B-protein
families	I-protein
,	O
as	O
well	O
as	O
the	O
cellular	B-protein
factors	I-protein
HEB-1	B-protein
and	O
p67SRF	B-protein
.	O

An	O
additional	O
distinguishing	O
characteristic	O
of	O
HTLV-I	O
infection	O
is	O
the	O
profound	O
state	O
of	O
viral	O
latency	O
that	O
is	O
present	O
in	O
circulating	O
primary	B-cell_type
leukemic	I-cell_type
T	I-cell_type
cells	I-cell_type
.	O

In	O
this	O
study	O
,	O
we	O
demonstrate	O
that	O
HTLV-I	O
Tax	B-protein
can	O
physically	O
associate	O
with	O
p100	B-protein
,	O
the	O
product	O
of	O
the	O
Rel-related	B-DNA
NF-kappa	I-DNA
B2	I-DNA
gene	I-DNA
,	O
both	O
in	O
transfected	B-cell_line
cells	I-cell_line
and	O
in	O
HTLV-I-infected	B-cell_line
leukemic	I-cell_line
T-cell	I-cell_line
lines	I-cell_line
.	O

Furthermore	O
,	O
the	O
physical	O
interaction	O
of	O
Tax	B-protein
with	O
p100	B-protein
leads	O
to	O
the	O
inhibition	O
of	O
Tax	B-protein
-induced	O
activation	O
of	O
the	O
HTLV-I	O
and	O
human	B-DNA
immunodeficiency	I-DNA
virus	I-DNA
type	I-DNA
1	I-DNA
long	I-DNA
terminal	I-DNA
repeats	I-DNA
,	O
reflecting	O
p100	B-protein
-mediated	O
cytoplasmic	O
sequestration	O
of	O
the	O
normally	O
nuclearly	O
expressed	O
Tax	B-protein
protein	I-protein
.	O

In	O
contrast	O
,	O
a	O
mutant	O
of	O
Tax	B-protein
that	O
selectively	O
fails	O
to	O
activate	O
nuclear	O
NF-kappa	B-protein
B	I-protein
expression	O
does	O
not	O
associate	O
with	O
p100	B-protein
.	O

(	O
ABSTRACT	O
TRUNCATED	O
AT	O
250	O
WORDS	O
)	O

MOLECULAR	NULL
AnD	NULL
CELLULAR	NULL
BroLOGY	NULL
,	NULL
Feb.	NULL
1994	NULL
,	NULL
p.	NULL
1374-1382	NULL
0270-7306/94/	NULL
$	NULL
04.00+0	NULL
Copyright	NULL
©	NULL
1994	NULL
,	NULL
American	NULL
Society	NULL
for	NULL
Microbiology	NULL
Vol	NULL
.	NULL

14	NULL
,	NULL
No	NULL
.	NULL

2	NULL
Human	NULL
T-Cell	NULL
Leukemia	NULL
Virus	NULL
Type	NULL
I	NULL
Tax	NULL
Associates	NULL
with	NULL
and	NULL
Is	NULL
Negatively	NULL
Regulated	NULL
by	NULL
the	NULL
p100	NULL
Gene	NULL
Product	NULL
:	NULL
Implications	NULL
for	NULL
Viral	NULL
Latency	NULL
CHRISTOPHE	NULL
BERAUD	NULL
,	NULL
'	NULL
SHAO-CONG	NULL
SUN	NULL
,	NULL
PARHAM	NULL
GANCHI	NULL
,	NULL
'	NULL
DEAN	NULL
W.	NULL
BALLARD	NULL
,	NULL
``	NULL
AND	NULL
WARNER	NULL
C.	NULL
GREENE	NULL
'	NULL
``	NULL
*	NULL
Gladstone	NULL
Institute	NULL
of	NULL
Virology	NULL
and	NULL
Immunology	NULL
,	NULL
University	NULL
of	NULL
California	NULL
,	NULL
San	NULL
Francisco	NULL
,	NULL
and	NULL
San	NULL
Francisco	NULL
General	NULL
Hospital	NULL
,	NULL
San	NULL
Francisco	NULL
,	NULL
California	NULL
94141-9100	NULL
,	NULL
*	NULL
and	NULL
Howard	NULL
Hughes	NULL
Medical	NULL
Institute	NULL
,	NULL
Vanderbilt	NULL
University	NULL
,	NULL
Nashville	NULL
,	NULL
Tennessee	NULL
37232-0295	NULL
Received	NULL
23	NULL
July	NULL
1993/Returned	NULL
for	NULL
modification	NULL
2	NULL
September	NULL
1993/Accepted	NULL
4	NULL
November	NULL
1993	NULL
Human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
I	NULL
(	NULL
HTLV-I	NULL
)	NULL
is	NULL
the	NULL
etiologic	NULL
agent	NULL
of	NULL
the	NULL
adult	NULL
T-cell	NULL
leukemia	NULL
,	NULL
an	NULL
aggressive	NULL
and	NULL
often	NULL
fatal	NULL
malignancy	NULL
of	NULL
activated	NULL
human	NULL
CD4	NULL
T	NULL
cells	NULL
.	NULL

HTLV-I	NULL
encodes	NULL
an	NULL
essential	NULL
40-kDa	NULL
protein	NULL
termed	NULL
Tax	NULL
that	NULL
not	NULL
only	NULL
transactivates	NULL
the	NULL
long	NULL
terminal	NULL
repeat	NULL
of	NULL
this	NULL
retrovirus	NULL
but	NULL
also	NULL
induces	NULL
an	NULL
array	NULL
of	NULL
cellular	NULL
genes	NULL
.	NULL

Tax-mediated	NULL
transformation	NULL
of	NULL
T	NULL
cells	NULL
likely	NULL
involves	NULL
the	NULL
deregulated	NULL
expression	NULL
of	NULL
various	NULL
cellular	NULL
genes	NULL
that	NULL
normally	NULL
regulate	NULL
lymphocyte	NULL
growth	NULL
produced	NULL
by	NULL
altered	NULL
activity	NULL
of	NULL
various	NULL
endogenous	NULL
host	NULL
transcription	NULL
factors	NULL
.	NULL

In	NULL
particular	NULL
,	NULL
Tax	NULL
is	NULL
capable	NULL
of	NULL
modulating	NULL
the	NULL
expression	NULL
or	NULL
activity	NULL
of	NULL
various	NULL
host	NULL
transcription	NULL
factors	NULL
,	NULL
including	NULL
members	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B/Rel	NULL
and	NULL
CREB/ATF	NULL
families	NULL
,	NULL
as	NULL
well	NULL
as	NULL
the	NULL
cellular	NULL
factors	NULL
HEB-1	NULL
and	NULL
p67°	NULL
``	NULL
~	NULL
``	NULL
.	NULL

An	NULL
additional	NULL
distinguishing	NULL
characteristic	NULL
of	NULL
HTLV-I	NULL
infection	NULL
is	NULL
the	NULL
profound	NULL
state	NULL
of	NULL
viral	NULL
latency	NULL
that	NULL
is	NULL
present	NULL
in	NULL
circulating	NULL
primary	NULL
leukemic	NULL
T	NULL
cells	NULL
.	NULL

In	NULL
this	NULL
study	NULL
,	NULL
we	NULL
demonstrate	NULL
that	NULL
HTLV-I	NULL
Tax	NULL
can	NULL
physically	NULL
associate	NULL
with	NULL
p100	NULL
,	NULL
the	NULL
product	NULL
of	NULL
the	NULL
Rel-related	NULL
NF-	NULL
«	NULL
B2	NULL
gene	NULL
,	NULL
both	NULL
in	NULL
transfected	NULL
cells	NULL
and	NULL
in	NULL
HTLV-I-infected	NULL
leukemic	NULL
T-cell	NULL
lines	NULL
.	NULL

Furthermore	NULL
,	NULL
the	NULL
physical	NULL
interaction	NULL
of	NULL
Tax	NULL
with	NULL
p100	NULL
leads	NULL
to	NULL
the	NULL
inhibition	NULL
of	NULL
Tax-induced	NULL
activation	NULL
of	NULL
the	NULL
HTLV-I	NULL
and	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
long	NULL
terminal	NULL
repeats	NULL
,	NULL
reflecting	NULL
p100-mediated	NULL
cytoplasmic	NULL
sequestration	NULL
of	NULL
the	NULL
normally	NULL
nuclearly	NULL
expressed	NULL
Tax	NULL
protein	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
a	NULL
mutant	NULL
of	NULL
Tax	NULL
that	NULL
selectively	NULL
fails	NULL
to	NULL
activate	NULL
nuclear	NULL
NF-scB	NULL
expression	NULL
does	NULL
not	NULL
associate	NULL
with	NULL
p100	NULL
.	NULL

Together	NULL
,	NULL
these	NULL
results	NULL
suggest	NULL
that	NULL
the	NULL
cytoplasmic	NULL
interplay	NULL
of	NULL
Tax	NULL
and	NULL
p100	NULL
may	NULL
play	NULL
an	NULL
important	NULL
role	NULL
in	NULL
the	NULL
initiation	NULL
and	NULL
maintenance	NULL
of	NULL
HTLV-I	NULL
latency	NULL
observed	NULL
in	NULL
adult	NULL
T-cell	NULL
leukemia	NULL
.	NULL

Human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
I	NULL
(	NULL
HTLV-I	NULL
)	NULL
is	NULL
a	NULL
type	NULL
C	NULL
retrovirus	NULL
that	NULL
has	NULL
been	NULL
etiologically	NULL
linked	NULL
with	NULL
adult	NULL
T-cell	NULL
leukemia	NULL
(	NULL
ATL	NULL
)	NULL
(	NULL
61	NULL
,	NULL
87	NULL
)	NULL
and	NULL
more	NULL
recently	NULL
with	NULL
a	NULL
chronic	NULL
demyelinating	NULL
disease	NULL
termed	NULL
tropical	NULL
spastic	NULL
paraparesis	NULL
(	NULL
30	NULL
,	NULL
60	NULL
)	NULL
.	NULL

ATL	NULL
is	NULL
geographically	NULL
localized	NULL
in	NULL
regions	NULL
of	NULL
the	NULL
world	NULL
where	NULL
HTLV-I	NULL
infection	NULL
is	NULL
endemic	NULL
,	NULL
notably	NULL
southern	NULL
Japan	NULL
,	NULL
sub-Saharan	NULL
Africa	NULL
,	NULL
the	NULL
Caribbean	NULL
basin	NULL
,	NULL
and	NULL
parts	NULL
of	NULL
the	NULL
southeastern	NULL
United	NULL
States	NULL
(	NULL
11	NULL
,	NULL
12	NULL
,	NULL
17	NULL
,	NULL
23	NULL
,	NULL
27	NULL
,	NULL
32	NULL
,	NULL
39	NULL
,	NULL
48	NULL
)	NULL
.	NULL

This	NULL
highly	NULL
aggressive	NULL
and	NULL
often	NULL
fatal	NULL
neoplasm	NULL
of	NULL
CD4	NULL
T	NULL
cells	NULL
is	NULL
frequently	NULL
characterized	NULL
by	NULL
tumor	NULL
cell	NULL
invasion	NULL
of	NULL
skin	NULL
and	NULL
lymph	NULL
nodes	NULL
and	NULL
may	NULL
be	NULL
associated	NULL
with	NULL
hypercal-cemia	NULL
and	NULL
osteolysis	NULL
(	NULL
11	NULL
,	NULL
12	NULL
,	NULL
17	NULL
,	NULL
32	NULL
,	NULL
44	NULL
,	NULL
47	NULL
,	NULL
83	NULL
)	NULL
.	NULL

Although	NULL
the	NULL
precise	NULL
mechanism	NULL
(	NULL
s	NULL
)	NULL
is	NULL
not	NULL
well	NULL
understood	NULL
,	NULL
several	NULL
independent	NULL
lines	NULL
of	NULL
evidence	NULL
suggest	NULL
that	NULL
the	NULL
HTLV-I-encoded	NULL
transactivator	NULL
,	NULL
Tax	NULL
,	NULL
plays	NULL
a	NULL
central	NULL
role	NULL
in	NULL
CD4	NULL
T-cell	NULL
transformation	NULL
.	NULL

Specifically	NULL
,	NULL
Tax	NULL
transforms	NULL
mouse	NULL
or	NULL
rat	NULL
fibroblastoid	NULL
cell	NULL
lines	NULL
(	NULL
73	NULL
,	NULL
82	NULL
)	NULL
or	NULL
primary	NULL
rat	NULL
fibroblasts	NULL
in	NULL
cooperation	NULL
with	NULL
the	NULL
ras	NULL
oncogene	NULL
(	NULL
62	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
transgenic	NULL
mice	NULL
expressing	NULL
Tax	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
develop	NULL
mesenchymal	NULL
tumors	NULL
(	NULL
38	NULL
,	NULL
56	NULL
)	NULL
.	NULL

However	NULL
,	NULL
the	NULL
long	NULL
period	NULL
of	NULL
clinical	NULL
latency	NULL
coupled	NULL
with	NULL
the	NULL
low	NULL
incidence	NULL
of	NULL
ATL	NULL
development	NULL
in	NULL
HTLV-I-infected	NULL
individuals	NULL
(	NULL
<	NULL
1	NULL
%	NULL
)	NULL
suggests	NULL
that	NULL
a	NULL
multistep	NULL
process	NULL
of	NULL
transformation	NULL
is	NULL
likely	NULL
involved	NULL
(	NULL
72	NULL
)	NULL
.	NULL

In	NULL
this	NULL
regard	NULL
,	NULL
mutations	NULL
in	NULL
the	NULL
p53	NULL
tumor	NULL
*	NULL
Corresponding	NULL
author	NULL
.	NULL

Mailing	NULL
address	NULL
:	NULL
Gladstone	NULL
Institute	NULL
of	NULL
Virology	NULL
and	NULL
Immunology	NULL
,	NULL
P.O	NULL
.	NULL

Box	NULL
419100	NULL
,	NULL
San	NULL
Francisco	NULL
,	NULL
CA	NULL
94141-9100	NULL
.	NULL

Phone	NULL
:	NULL
(	NULL
415	NULL
)	NULL
695-3800	NULL
.	NULL

Fax	NULL
:	NULL
(	NULL
415	NULL
)	NULL
826-1617	NULL
.	NULL

Electronic	NULL
mail	NULL
address	NULL
:	NULL
Warner__Greene	NULL
@	NULL
quickmail.ucsf.edu	NULL
.	NULL

1374	NULL
suppressor	NULL
gene	NULL
have	NULL
recently	NULL
been	NULL
detected	NULL
in	NULL
some	NULL
ATL	NULL
cell	NULL
lines	NULL
,	NULL
raising	NULL
the	NULL
possibility	NULL
that	NULL
the	NULL
altered	NULL
function	NULL
of	NULL
this	NULL
particular	NULL
cellular	NULL
protein	NULL
may	NULL
contribute	NULL
to	NULL
the	NULL
development	NULL
of	NULL
leukemia	NULL
(	NULL
18	NULL
,	NULL
67	NULL
)	NULL
.	NULL

Tax	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
activate	NULL
an	NULL
array	NULL
of	NULL
transcription	NULL
units	NULL
,	NULL
including	NULL
the	NULL
HTLV-I	NULL
long	NULL
terminal	NULL
repeat	NULL
(	NULL
LTR	NULL
)	NULL
itself	NULL
(	NULL
19	NULL
,	NULL
75	NULL
)	NULL
,	NULL
the	NULL
proto-oncogene	NULL
c-fos	NULL
(	NULL
1	NULL
,	NULL
25	NULL
,	NULL
54	NULL
)	NULL
,	NULL
the	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
(	NULL
HIV-1	NULL
)	NULL
LTR	NULL
(	NULL
13	NULL
)	NULL
,	NULL
and	NULL
various	NULL
cellular	NULL
genes	NULL
involved	NULL
in	NULL
T-cell	NULL
growth	NULL
,	NULL
including	NULL
the	NULL
interleukin-2	NULL
gene	NULL
(	NULL
50	NULL
,	NULL
70	NULL
)	NULL
and	NULL
the	NULL
a	NULL
subunit	NULL
of	NULL
its	NULL
high-affinity	NULL
receptor	NULL
(	NULL
21	NULL
,	NULL
42	NULL
,	NULL
70	NULL
)	NULL
.	NULL

The	NULL
ability	NULL
of	NULL
Tax	NULL
to	NULL
induce	NULL
the	NULL
expression	NULL
of	NULL
growth-related	NULL
genes	NULL
that	NULL
normally	NULL
mediate	NULL
physiologic	NULL
T-cell	NULL
activation	NULL
and	NULL
cell	NULL
cycle	NULL
progression	NULL
provides	NULL
one	NULL
attractive	NULL
explanation	NULL
for	NULL
the	NULL
polyclonal	NULL
proliferation	NULL
of	NULL
T	NULL
cells	NULL
observed	NULL
early	NULL
after	NULL
HTLV-I	NULL
infection	NULL
(	NULL
35	NULL
)	NULL
.	NULL

This	NULL
initial	NULL
proliferative	NULL
response	NULL
presumably	NULL
serves	NULL
to	NULL
facilitate	NULL
the	NULL
occurrence	NULL
of	NULL
subsequent	NULL
undefined	NULL
genetic	NULL
events	NULL
that	NULL
complete	NULL
the	NULL
transformation	NULL
process	NULL
.	NULL

In	NULL
light	NULL
of	NULL
the	NULL
inability	NULL
of	NULL
Tax	NULL
to	NULL
directly	NULL
engage	NULL
DNA	NULL
,	NULL
the	NULL
unusually	NULL
large	NULL
number	NULL
of	NULL
cellular	NULL
genes	NULL
activated	NULL
by	NULL
this	NULL
retroviral	NULL
protein	NULL
is	NULL
likely	NULL
explained	NULL
by	NULL
its	NULL
capacity	NULL
to	NULL
modulate	NULL
various	NULL
host	NULL
transcription	NULL
factor	NULL
pathways	NULL
.	NULL

These	NULL
pathways	NULL
include	NULL
the	NULL
CREB/ATF	NULL
family	NULL
of	NULL
proteins	NULL
and	NULL
the	NULL
HEB-1	NULL
cellular	NULL
factor	NULL
responsible	NULL
for	NULL
activation	NULL
of	NULL
the	NULL
HTLV-I	NULL
LTR	NULL
(	NULL
9	NULL
,	NULL
81	NULL
,	NULL
89	NULL
,	NULL
90	NULL
)	NULL
,	NULL
the	NULL
p67°®	NULL
``	NULL
factor	NULL
which	NULL
mediates	NULL
induction	NULL
of	NULL
c-fos	NULL
(	NULL
26	NULL
)	NULL
,	NULL
and	NULL
the	NULL
NF-	NULL
«	NULL
B/Rei	NULL
family	NULL
which	NULL
mediate	NULL
activation	NULL
of	NULL
the	NULL
interleukin-2	NULL
receptor	NULL
«	NULL
-sub-unit	NULL
gene	NULL
and	NULL
the	NULL
HIV-1	NULL
LTR	NULL
(	NULL
7	NULL
,	NULL
13	NULL
,	NULL
20	NULL
,	NULL
64	NULL
)	NULL
.	NULL

Indeed	NULL
,	NULL
Tax	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
physically	NULL
interact	NULL
with	NULL
some	NULL
of	NULL
these	NULL
factors	NULL
(	NULL
9	NULL
,	NULL
26	NULL
,	NULL
40	NULL
,	NULL
81	NULL
,	NULL
89	NULL
,	NULL
90	NULL
)	NULL
.	NULL

Vor	NULL
.	NULL

14	NULL
,	NULL
1994	NULL
Members	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
xB/Rel	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
are	NULL
each	NULL
characterized	NULL
by	NULL
an	NULL
N-terminal	NULL
~300-amino-acid	NULL
segment	NULL
termed	NULL
the	NULL
Rel	NULL
homology	NULL
domain	NULL
.	NULL

This	NULL
domain	NULL
is	NULL
responsible	NULL
for	NULL
DNA	NULL
binding	NULL
,	NULL
dimerization	NULL
,	NULL
and	NULL
nuclear	NULL
localization	NULL
of	NULL
these	NULL
factors	NULL
(	NULL
33	NULL
,	NULL
34	NULL
)	NULL
.	NULL

Members	NULL
of	NULL
the	NULL
Rel	NULL
family	NULL
include	NULL
the	NULL
oncoprotein	NULL
v-Rel	NULL
(	NULL
77	NULL
,	NULL
85	NULL
)	NULL
,	NULL
its	NULL
cellular	NULL
homolog	NULL
c-Rel	NULL
(	NULL
16	NULL
)	NULL
,	NULL
p50	NULL
(	NULL
31	NULL
,	NULL
46	NULL
,	NULL
53	NULL
)	NULL
,	NULL
p52	NULL
(	NULL
15	NULL
,	NULL
57	NULL
,	NULL
68	NULL
)	NULL
,	NULL
p65	NULL
(	NULL
58	NULL
,	NULL
65	NULL
)	NULL
,	NULL
ReIB	NULL
(	NULL
66	NULL
)	NULL
,	NULL
and	NULL
the	NULL
Drosophila	NULL
morphogen	NULL
Dorsal	NULL
(	NULL
78	NULL
)	NULL
.	NULL

Heterodimeric	NULL
combinations	NULL
of	NULL
p50	NULL
and	NULL
p65	NULL
constitute	NULL
the	NULL
prototypical	NULL
NF-	NULL
«	NULL
B	NULL
complex	NULL
(	NULL
6	NULL
)	NULL
,	NULL
which	NULL
stimulates	NULL
transcription	NULL
by	NULL
a	NULL
mechanism	NULL
involving	NULL
a	NULL
potent	NULL
transactivation	NULL
domain	NULL
located	NULL
within	NULL
the	NULL
C-terminal	NULL
half	NULL
of	NULL
p65	NULL
(	NULL
8	NULL
,	NULL
65	NULL
,	NULL
69	NULL
)	NULL
.	NULL

Both	NULL
p50	NULL
and	NULL
p52	NULL
are	NULL
proteolytic	NULL
cleavage	NULL
products	NULL
of	NULL
larger	NULL
precursor	NULL
proteins	NULL
,	NULL
termed	NULL
p105	NULL
(	NULL
NF-	NULL
«	NULL
B1	NULL
gene	NULL
product	NULL
)	NULL
(	NULL
14	NULL
,	NULL
22	NULL
,	NULL
31	NULL
,	NULL
46	NULL
,	NULL
53	NULL
)	NULL
and	NULL
p100	NULL
(	NULL
NF-	NULL
«	NULL
B2	NULL
gene	NULL
product	NULL
)	NULL
(	NULL
15	NULL
,	NULL
51	NULL
,	NULL
57	NULL
,	NULL
68	NULL
)	NULL
,	NULL
respectively	NULL
.	NULL

One	NULL
unique	NULL
feature	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B/Re	NULL
!	NULL

transcription	NULL
factor	NULL
system	NULL
is	NULL
that	NULL
the	NULL
involved	NULL
factors	NULL
are	NULL
regulated	NULL
posttran-scriptionally	NULL
through	NULL
interactions	NULL
with	NULL
a	NULL
set	NULL
of	NULL
cytoplasmic	NULL
inhibitory	NULL
proteins	NULL
termed	NULL
IxB	NULL
(	NULL
3-5	NULL
,	NULL
84	NULL
)	NULL
.	NULL

Each	NULL
of	NULL
these	NULL
inhibitors	NULL
contains	NULL
a	NULL
domain	NULL
remarkable	NULL
for	NULL
the	NULL
presence	NULL
of	NULL
multiple	NULL
ankyrin	NULL
motifs	NULL
which	NULL
appear	NULL
to	NULL
be	NULL
essential	NULL
for	NULL
their	NULL
biological	NULL
functions	NULL
.	NULL

The	NULL
IxB	NULL
proteins	NULL
identified	NULL
so	NULL
far	NULL
include	NULL
IxBa	NULL
(	NULL
formerly	NULL
called	NULL
IxB/MAD3	NULL
)	NULL
(	NULL
36	NULL
,	NULL
88	NULL
)	NULL
,	NULL
IxBB	NULL
(	NULL
88	NULL
)	NULL
,	NULL
IxBy	NULL
,	NULL
which	NULL
corresponds	NULL
to	NULL
the	NULL
C-terminal	NULL
half	NULL
of	NULL
p105	NULL
(	NULL
37	NULL
,	NULL
43	NULL
,	NULL
49	NULL
)	NULL
,	NULL
Bel-3	NULL
(	NULL
24	NULL
,	NULL
37	NULL
,	NULL
59	NULL
,	NULL
86	NULL
)	NULL
,	NULL
and	NULL
the	NULL
Drosophila	NULL
maternal	NULL
protein	NULL
Cactus	NULL
(	NULL
29	NULL
,	NULL
45	NULL
)	NULL
.	NULL

Remarkably	NULL
,	NULL
the	NULL
p105	NULL
(	NULL
55	NULL
,	NULL
63	NULL
)	NULL
and	NULL
p100	NULL
(	NULL
52	NULL
,	NULL
80	NULL
)	NULL
precursors	NULL
of	NULL
p50	NULL
and	NULL
p52	NULL
also	NULL
contain	NULL
C-terminal	NULL
ankyrin	NULL
repeats	NULL
and	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
possess	NULL
IxB-like	NULL
biological	NULL
activities	NULL
.	NULL

In	NULL
this	NULL
report	NULL
,	NULL
we	NULL
demonstrate	NULL
that	NULL
HTLV-I	NULL
Tax	NULL
specifically	NULL
interacts	NULL
with	NULL
the	NULL
p100	NULL
protein	NULL
product	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B2	NULL
gene	NULL
.	NULL

Surprisingly	NULL
,	NULL
only	NULL
a	NULL
weak	NULL
interaction	NULL
was	NULL
detected	NULL
between	NULL
Tax	NULL
and	NULL
the	NULL
p105	NULL
protein	NULL
product	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B1	NULL
gene	NULL
.	NULL

Functionally	NULL
,	NULL
the	NULL
interaction	NULL
of	NULL
p100	NULL
and	NULL
Tax	NULL
results	NULL
in	NULL
the	NULL
marked	NULL
down-regulation	NULL
of	NULL
Tax-mediated	NULL
activation	NULL
of	NULL
the	NULL
HTLV-I	NULL
LTR	NULL
.	NULL

These	NULL
inhibitory	NULL
effects	NULL
of	NULL
p100	NULL
are	NULL
correlated	NULL
with	NULL
the	NULL
redistribution	NULL
of	NULL
Tax	NULL
from	NULL
the	NULL
nuclear	NULL
to	NULL
the	NULL
cytoplasmic	NULL
compartment	NULL
.	NULL

These	NULL
findings	NULL
suggest	NULL
that	NULL
the	NULL
formation	NULL
of	NULL
Tax-p100	NULL
complexes	NULL
in	NULL
virally	NULL
infected	NULL
cells	NULL
may	NULL
play	NULL
an	NULL
important	NULL
role	NULL
in	NULL
the	NULL
establishment	NULL
and	NULL
maintenance	NULL
of	NULL
viral	NULL
latency	NULL
observed	NULL
in	NULL
HTLV-I-induced	NULL
ATL	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Plasmids	NULL
.	NULL

Tax	NULL
,	NULL
TaxM22	NULL
,	NULL
TaxM47	NULL
(	NULL
71	NULL
)	NULL
,	NULL
p100	NULL
,	NULL
p52	NULL
(	NULL
68	NULL
)	NULL
,	NULL
IxBa	NULL
(	NULL
36	NULL
)	NULL
,	NULL
p105	NULL
(	NULL
46	NULL
)	NULL
,	NULL
and	NULL
p65	NULL
(	NULL
65	NULL
)	NULL
cDNAs	NULL
were	NULL
subcloned	NULL
within	NULL
the	NULL
polylinker	NULL
of	NULL
the	NULL
pCMV4	NULL
expression	NULL
vector	NULL
positioned	NULL
downstream	NULL
of	NULL
the	NULL
cytomegalovirus	NULL
immediate-early	NULL
promoter	NULL
(	NULL
2	NULL
)	NULL
.	NULL

Reporter	NULL
plasmids	NULL
contained	NULL
either	NULL
the	NULL
full-length	NULL
HTLV-I	NULL
LTR	NULL
(	NULL
75	NULL
)	NULL
or	NULL
the	NULL
HIV-1	NULL
xB	NULL
enhancer	NULL
cassette	NULL
linked	NULL
to	NULL
a	NULL
heterologous	NULL
TATA	NULL
box	NULL
(	NULL
76	NULL
)	NULL
,	NULL
cloned	NULL
immediately	NULL
upstream	NULL
of	NULL
the	NULL
gene	NULL
encoding	NULL
chloramphenicol	NULL
acetyltrans-ferase	NULL
(	NULL
CAT	NULL
)	NULL
.	NULL

Immunoprecipitation	NULL
analysis	NULL
.	NULL

Subconfluent	NULL
monkey	NULL
kidney	NULL
COS-7	NULL
cells	NULL
were	NULL
transfected	NULL
by	NULL
using	NULL
DEAE-dextran	NULL
(	NULL
41	NULL
)	NULL
.	NULL

Approximately	NULL
40	NULL
h	NULL
after	NULL
transfection	NULL
,	NULL
cells	NULL
were	NULL
starved	NULL
for	NULL
1	NULL
h	NULL
in	NULL
Dulbecco	NULL
modified	NULL
Eagle	NULL
medium	NULL
lacking	NULL
methionine	NULL
and	NULL
cysteine	NULL
and	NULL
then	NULL
metabolically	NULL
radiolabeled	NULL
for	NULL
3	NULL
h	NULL
with	NULL
[	NULL
°*S	NULL
)	NULL
methionine	NULL
and	NULL
[	NULL
**S	NULL
}	NULL
cysteine	NULL
(	NULL
300	NULL
pCi/ml	NULL
)	NULL
.	NULL

Whole-cell	NULL
extracts	NULL
were	NULL
prepared	NULL
by	NULL
resuspending	NULL
these	NULL
cells	NULL
in	NULL
500	NULL
jl	NULL
of	NULL
a	NULL
low-stringency	NULL
lysis	NULL
buffer	NULL
(	NULL
20	NULL
mM	NULL
N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic	NULL
acid	NULL
[	NULL
HEPES	NULL
;	NULL
pH	NULL
7.9	NULL
}	NULL
,	NULL
1	NULL
mM	NULL
MgCl	NULL
,	NULL
,	NULL
0.2	NULL
mM	NULL
EDTA	NULL
,	NULL
10	NULL
wM	NULL
ZnCl	NULL
;	NULL
,	NULL
,	NULL
10	NULL
%	NULL
glycerol	NULL
,	NULL
200	NULL
mM	NULL
KCI	NULL
,	NULL
0.2	NULL
%	NULL
Nonidet	NULL
P-40	NULL
,	NULL
0.5	NULL
mM	NULL
dithio-threitol	NULL
,	NULL
1	NULL
mM	NULL
phenylmethylsulfonyl	NULL
fluoride	NULL
)	NULL
;	NULL
200	NULL
wl	NULL
of	NULL
each	NULL
HTLV-I	NULL
Tax	NULL
IS	NULL
REGULATED	NULL
BY	NULL
NF-kB	NULL
p100	NULL
1375	NULL
extract	NULL
was	NULL
diluted	NULL
to	NULL
500	NULL
wl	NULL
in	NULL
the	NULL
same	NULL
buffer	NULL
and	NULL
precleared	NULL
for	NULL
1	NULL
h	NULL
at	NULL
4°C	NULL
with	NULL
1	NULL
pl	NULL
of	NULL
normal	NULL
rabbit	NULL
serum	NULL
(	NULL
NRS	NULL
)	NULL
and	NULL
20	NULL
pl	NULL
of	NULL
protein	NULL
A-agarose	NULL
beads	NULL
(	NULL
Boehringer	NULL
,	NULL
Mann-heim	NULL
,	NULL
Germany	NULL
)	NULL
.	NULL

The	NULL
precleared	NULL
extract	NULL
was	NULL
then	NULL
incubated	NULL
at	NULL
4°C	NULL
with	NULL
1	NULL
pl	NULL
of	NULL
the	NULL
specific	NULL
antibodies	NULL
and	NULL
10	NULL
pl	NULL
of	NULL
protein	NULL
A-agarose	NULL
beads	NULL
for	NULL
2	NULL
h.	NULL
The	NULL
agarose	NULL
beads	NULL
were	NULL
then	NULL
washed	NULL
twice	NULL
in	NULL
the	NULL
low-stringency	NULL
buffer	NULL
and	NULL
resuspended	NULL
in	NULL
30	NULL
pl	NULL
of	NULL
2	NULL
%	NULL
loading	NULL
buffer	NULL
(	NULL
0.125	NULL
M	NULL
Tris	NULL
[	NULL
pH	NULL
6.8	NULL
]	NULL
,	NULL
4	NULL
%	NULL
sodium	NULL
dodecyl	NULL
sulfate	NULL
[	NULL
SDS	NULL
]	NULL
,	NULL
10	NULL
%	NULL
B-mercaptoethanol	NULL
,	NULL
30	NULL
%	NULL
glycerol	NULL
,	NULL
0.01	NULL
%	NULL
bromophenol	NULL
blue	NULL
)	NULL
.	NULL

After	NULL
heat	NULL
denaturation	NULL
,	NULL
15	NULL
ul	NULL
of	NULL
the	NULL
sample	NULL
was	NULL
loaded	NULL
on	NULL
an	NULL
SDS-9	NULL
%	NULL
polyacrylamide	NULL
gel	NULL
.	NULL

Jurkat	NULL
cell	NULL
transfection	NULL
and	NULL
CAT	NULL
assay	NULL
.	NULL

Human	NULL
Jurkat	NULL
T	NULL
cells	NULL
were	NULL
cultured	NULL
in	NULL
RPMI	NULL
1640	NULL
medium	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
,	NULL
2	NULL
mM	NULL
glutamine	NULL
,	NULL
and	NULL
antibiotics	NULL
.	NULL

Cells	NULL
were	NULL
transfected	NULL
with	NULL
0.5	NULL
or	NULL
2	NULL
ug	NULL
of	NULL
CAT	NULL
reporter	NULL
plasmid	NULL
and	NULL
various	NULL
amounts	NULL
of	NULL
expression	NULL
plasmids	NULL
,	NULL
using	NULL
DEAE-dextran	NULL
(	NULL
41	NULL
)	NULL
.	NULL

DNA	NULL
concentration	NULL
was	NULL
held	NULL
constant	NULL
in	NULL
all	NULL
transfections	NULL
,	NULL
using	NULL
the	NULL
parental	NULL
pCMV4	NULL
vector	NULL
.	NULL

Approximately	NULL
40	NULL
h	NULL
after	NULL
transfection	NULL
,	NULL
relative	NULL
CAT	NULL
activities	NULL
were	NULL
determined	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
28	NULL
)	NULL
.	NULL

Indirect	NULL
immunofluorescence	NULL
.	NULL

COS-7	NULL
cells	NULL
were	NULL
cultured	NULL
in	NULL
four-well	NULL
chamber	NULL
slides	NULL
(	NULL
Nunc	NULL
,	NULL
Naperville	NULL
,	NULL
III	NULL
.	NULL
)	NULL

and	NULL
transfected	NULL
with	NULL
various	NULL
expression	NULL
plasmids	NULL
,	NULL
using	NULL
DEAE-dex-tran	NULL
.	NULL

Approximately	NULL
48	NULL
h	NULL
after	NULL
transfection	NULL
,	NULL
cells	NULL
were	NULL
fixed	NULL
,	NULL
permeabilized	NULL
,	NULL
and	NULL
stained	NULL
for	NULL
indirect	NULL
immunofluorescence	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
28	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
observed	NULL
with	NULL
a	NULL
UV	NULL
light	NULL
microscope	NULL
(	NULL
Leitz	NULL
,	NULL
Heerbrug	NULL
,	NULL
Switzerland	NULL
)	NULL
.	NULL

Immunoblot	NULL
analysis	NULL
of	NULL
ATL	NULL
cell	NULL
lines	NULL
.	NULL

The	NULL
HTLV-I-infected	NULL
cell	NULL
lines	NULL
HUT1O2	NULL
and	NULL
C8166	NULL
were	NULL
cultured	NULL
in	NULL
RPMI	NULL
1640	NULL
medium	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
,	NULL
2	NULL
mM	NULL
glutamine	NULL
,	NULL
and	NULL
antibiotics	NULL
.	NULL

Subcellular	NULL
protein	NULL
extracts	NULL
from	NULL
these	NULL
cells	NULL
were	NULL
prepared	NULL
and	NULL
immunoprecipitated	NULL
with	NULL
NRS	NULL
or	NULL
anti-Rex	NULL
,	NULL
anti-p100	NULL
,	NULL
and	NULL
anti-Tax	NULL
antibodies	NULL
.	NULL

Immunoprecipitates	NULL
were	NULL
fractionated	NULL
on	NULL
SDS-polyacryl-amide	NULL
gels	NULL
,	NULL
transferred	NULL
to	NULL
nitrocellulose	NULL
,	NULL
and	NULL
immunoblotted	NULL
with	NULL
anti-p100	NULL
or	NULL
anti-Tax	NULL
,	NULL
using	NULL
an	NULL
enhanced	NULL
chemilumines-cence	NULL
system	NULL
as	NULL
specified	NULL
by	NULL
the	NULL
manufacturer	NULL
(	NULL
Amersham	NULL
International	NULL
,	NULL
Amersham	NULL
,	NULL
England	NULL
)	NULL
.	NULL

RESULTS	NULL
Tax	NULL
physically	NULL
interacts	NULL
with	NULL
the	NULL
NF-	NULL
«	NULL
B2	NULL
gene	NULL
product	NULL
p100	NULL
through	NULL
its	NULL
N-terminal	NULL
domain	NULL
.	NULL

To	NULL
investigate	NULL
the	NULL
potential	NULL
interaction	NULL
of	NULL
Tax	NULL
with	NULL
p100	NULL
or	NULL
its	NULL
proteolytically	NULL
processed	NULL
form	NULL
,	NULL
p52	NULL
,	NULL
coimmunoprecipitation	NULL
experiments	NULL
were	NULL
performed	NULL
with	NULL
whole-cell	NULL
extracts	NULL
from	NULL
COS	NULL
cells	NULL
cotransfected	NULL
with	NULL
combinations	NULL
of	NULL
expression	NULL
vectors	NULL
encoding	NULL
p100	NULL
,	NULL
p52	NULL
,	NULL
and	NULL
Tax	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
)	NULL
.	NULL

After	NULL
transfection	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
metabolically	NULL
radiolabeled	NULL
with	NULL
[	NULL
**SJmethionine	NULL
and	NULL
[	NULL
**SJcysteine	NULL
,	NULL
and	NULL
the	NULL
cell	NULL
lysates	NULL
were	NULL
immunoprecipitated	NULL
with	NULL
an	NULL
antiserum	NULL
directed	NULL
against	NULL
either	NULL
the	NULL
C	NULL
terminus	NULL
of	NULL
Tax	NULL
or	NULL
the	NULL
N	NULL
terminus	NULL
of	NULL
p100	NULL
.	NULL

In	NULL
cells	NULL
transfected	NULL
with	NULL
Tax	NULL
alone	NULL
,	NULL
a	NULL
specific	NULL
band	NULL
of	NULL
40	NULL
kDa	NULL
corresponding	NULL
to	NULL
the	NULL
Tax	NULL
protein	NULL
was	NULL
specifically	NULL
immunoprecipitated	NULL
with	NULL
an	NULL
anti-Tax	NULL
antiserum	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
;	NULL
however	NULL
,	NULL
this	NULL
antibody	NULL
failed	NULL
to	NULL
cross-react	NULL
with	NULL
either	NULL
p100	NULL
or	NULL
p52	NULL
(	NULL
lanes	NULL
3	NULL
and	NULL
4	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
in	NULL
extracts	NULL
from	NULL
cells	NULL
cotransfected	NULL
with	NULL
Tax	NULL
and	NULL
p100	NULL
or	NULL
p52	NULL
,	NULL
both	NULL
p100	NULL
and	NULL
p52	NULL
were	NULL
coimmunoprecipitated	NULL
with	NULL
Tax	NULL
(	NULL
lanes	NULL
5	NULL
and	NULL
6	NULL
)	NULL
by	NULL
the	NULL
anti-Tax	NULL
antibody	NULL
.	NULL

Of	NULL
note	NULL
,	NULL
p52	NULL
was	NULL
also	NULL
detected	NULL
in	NULL
the	NULL
extracts	NULL
from	NULL
p100-transfected	NULL
cells	NULL
,	NULL
apparently	NULL
reflecting	NULL
physiological	NULL
processing	NULL
of	NULL
p100	NULL
to	NULL
p52	NULL
(	NULL
lane	NULL
5	NULL
)	NULL
.	NULL

Under	NULL
these	NULL
coimmunoprecipitation	NULL
conditions	NULL
,	NULL
Tax	NULL
consistently	NULL
bound	NULL
p100	NULL
more	NULL
avidly	NULL
than	NULL
p52	NULL
for	NULL
reasons	NULL
that	NULL
remain	NULL
unclear	NULL
(	NULL
compare	NULL
lanes	NULL
5	NULL
and	NULL
6	NULL
)	NULL
.	NULL

Complementary	NULL
coimmunoprecipitation	NULL
experiments	NULL
were	NULL
per	NULL
1376	NULL
BERAUD	NULL
ET	NULL
AL	NULL
.	NULL

Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

A	NULL
B	NULL
1	NULL
2	NULL
3	NULL
4	NULL
50	NULL
6	NULL
7	NULL
8	NULL
9	NULL
10	NULL
11	NULL
12	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
1T	NULL
B	NULL
200	NULL
97	NULL
-	NULL
«	NULL
ag	NULL
am	NULL
»	NULL
-	NULL
<	NULL
-p105	NULL
97	NULL
-	NULL
69	NULL
-69-	NULL
as-	NULL
to	NULL
a	NULL
we	NULL
==	NULL
-	NULL
<	NULL
-p50	NULL
«	NULL
»	NULL
_	NULL
db	NULL
--	NULL
Tax	NULL
46——	NULL
3°—	NULL
-	NULL
21-So	NULL
hs	NULL
S	NULL
,	NULL
s	NULL
,	NULL
3	NULL
*	NULL
***	NULL
a*	NULL
,	NULL
*	NULL
Ks	NULL
o-Tax	NULL
a-p105	NULL
N	NULL
C	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
10	NULL
11	NULL
12	NULL
13	NULL
14	NULL
15	NULL
16	NULL
17	NULL
18	NULL
19	NULL
20	NULL
21	NULL
22	NULL
23	NULL
24	NULL
200-	NULL
200	NULL
i.	NULL
ds	NULL
-	NULL
<	NULL
-p100	NULL
g	NULL
Q	NULL
``	NULL
97	NULL
-	NULL
or-e9-	NULL
i-oe	NULL
-	NULL
<	NULL
-p62	NULL
coun	NULL
Siggy	NULL
maw	NULL
<	NULL
a	NULL
come	NULL
UBD	NULL
AD	NULL
a-	NULL
152	NULL
*-	NULL
-in	NULL
:	NULL
16=	NULL
~	NULL
S	NULL
--	NULL
-	NULL
Tax	NULL
30	NULL
-	NULL
30-CCS	NULL
CCL	NULL
k	NULL
k	NULL
k	NULL
So	NULL
K	NULL
,	NULL
he	NULL
Nake	NULL
kK	NULL
ﬁﬁ	NULL
‘	NULL
e	NULL
‘	NULL
b	NULL
'	NULL
q	NULL
,	NULL
ﬁ	NULL
‘	NULL
qﬁo	NULL
”	NULL
e	NULL
ﬁﬁ	NULL
‘	NULL
e	NULL
‘	NULL
b	NULL
‘	NULL
kﬁm	NULL
‘	NULL
e	NULL
wk	NULL
.	NULL

$	NULL
743	NULL
``	NULL
!	NULL

”	NULL
$	NULL
542	NULL
:	NULL
f	NULL
o-Tax	NULL
a-p100	NULL
N	NULL
FIG	NULL
.	NULL

1	NULL
.	NULL

Physical	NULL
interaction	NULL
of	NULL
HTLV-I	NULL
Tax	NULL
with	NULL
the	NULL
NF-	NULL
«	NULL
B2	NULL
gene	NULL
product	NULL
p100	NULL
and	NULL
its	NULL
processed	NULL
product	NULL
p52	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Coimmunoprecipitation	NULL
of	NULL
Tax	NULL
and	NULL
p100	NULL
or	NULL
p52	NULL
.	NULL

Subconfluent	NULL
COS-7	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
the	NULL
parental	NULL
control	NULL
expression	NULL
vector	NULL
pCMV4	NULL
(	NULL
lanes	NULL
1	NULL
and	NULL
7	NULL
)	NULL
,	NULL
Tax	NULL
(	NULL
lanes	NULL
2	NULL
and	NULL
8	NULL
)	NULL
,	NULL
p100	NULL
(	NULL
lanes	NULL
3	NULL
and	NULL
9	NULL
)	NULL
,	NULL
p52	NULL
(	NULL
lanes	NULL
4	NULL
and	NULL
10	NULL
)	NULL
,	NULL
or	NULL
combinations	NULL
of	NULL
Tax	NULL
and	NULL
p100	NULL
(	NULL
lanes	NULL
5	NULL
and	NULL
11	NULL
)	NULL
or	NULL
Tax	NULL
and	NULL
p52	NULL
(	NULL
lanes	NULL
6	NULL
and	NULL
12	NULL
)	NULL
.	NULL

Approximately	NULL
40	NULL
h	NULL
after	NULL
transfection	NULL
,	NULL
cells	NULL
were	NULL
metabolically	NULL
radiolabeled	NULL
and	NULL
whole-cell	NULL
extracts	NULL
were	NULL
prepared	NULL
.	NULL

These	NULL
extracts	NULL
were	NULL
then	NULL
subjected	NULL
to	NULL
immunoprecipitation	NULL
with	NULL
antiserum	NULL
specific	NULL
for	NULL
the	NULL
C	NULL
terminus	NULL
of	NULL
Tax	NULL
(	NULL
amino	NULL
acids	NULL
321	NULL
to	NULL
353	NULL
;	NULL
lanes	NULL
1	NULL
to	NULL
6	NULL
)	NULL
or	NULL
the	NULL
N	NULL
terminus	NULL
of	NULL
p100	NULL
(	NULL
amino	NULL
acids	NULL
1	NULL
to	NULL
21	NULL
;	NULL
lanes	NULL
7	NULL
to	NULL
12	NULL
)	NULL
.	NULL

Immunoprecipitates	NULL
were	NULL
analyzed	NULL
by	NULL
electrophoresis	NULL
on	NULL
an	NULL
SDS-9	NULL
%	NULL
polyacrylamide	NULL
gel	NULL
.	NULL

The	NULL
p100	NULL
,	NULL
p52	NULL
,	NULL
and	NULL
Tax	NULL
proteins	NULL
are	NULL
identified	NULL
by	NULL
labeled	NULL
arrows	NULL
on	NULL
the	NULL
right	NULL
;	NULL
the	NULL
migration	NULL
of	NULL
known	NULL
molecular	NULL
weight	NULL
markers	NULL
is	NULL
identified	NULL
in	NULL
kilodaltons	NULL
on	NULL
the	NULL
left	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Coimmunoprecipitation	NULL
studies	NULL
of	NULL
Tax	NULL
and	NULL
the	NULL
NF-kB1	NULL
gene	NULL
product	NULL
p105	NULL
.	NULL

Subconfluent	NULL
COS-7	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
the	NULL
parental	NULL
control	NULL
expression	NULL
vector	NULL
pCMV4	NULL
(	NULL
lanes	NULL
1	NULL
and	NULL
5	NULL
)	NULL
,	NULL
Tax	NULL
(	NULL
lanes	NULL
2	NULL
and	NULL
6	NULL
)	NULL
,	NULL
p105	NULL
(	NULL
lanes	NULL
3	NULL
and	NULL
7	NULL
)	NULL
,	NULL
or	NULL
a	NULL
combination	NULL
of	NULL
Tax	NULL
and	NULL
p105	NULL
(	NULL
lanes	NULL
4	NULL
and	NULL
8	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
identically	NULL
radiolabeled	NULL
,	NULL
and	NULL
extracts	NULL
were	NULL
immunoprecipitated	NULL
with	NULL
anti-Tax	NULL
(	NULL
lanes	NULL
1	NULL
to	NULL
4	NULL
)	NULL
or	NULL
antibody	NULL
specific	NULL
for	NULL
the	NULL
N	NULL
terminus	NULL
of	NULL
p105	NULL
(	NULL
amino	NULL
acids	NULL
1	NULL
to	NULL
21	NULL
;	NULL
lanes	NULL
5	NULL
to	NULL
8	NULL
)	NULL
.	NULL

The	NULL
p105	NULL
,	NULL
p50	NULL
,	NULL
and	NULL
Tax	NULL
proteins	NULL
are	NULL
identified	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Mutant	NULL
TaxM22	NULL
fails	NULL
to	NULL
interact	NULL
with	NULL
p100	NULL
or	NULL
p52	NULL
,	NULL
while	NULL
mutant	NULL
TaxM47	NULL
still	NULL
binds	NULL
to	NULL
p100	NULL
and	NULL
p52	NULL
.	NULL

Subconfluent	NULL
COS-7	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
the	NULL
parental	NULL
expression	NULL
vector	NULL
pCMV4	NULL
(	NULL
lanes	NULL
1	NULL
and	NULL
13	NULL
)	NULL
,	NULL
Tax	NULL
(	NULL
lanes	NULL
2	NULL
and	NULL
14	NULL
)	NULL
,	NULL
TaxM22	NULL
(	NULL
lanes	NULL
3	NULL
and	NULL
15	NULL
)	NULL
,	NULL
TaxM47	NULL
(	NULL
lanes	NULL
4	NULL
and	NULL
16	NULL
)	NULL
,	NULL
p100	NULL
(	NULL
lanes	NULL
5	NULL
and	NULL
17	NULL
)	NULL
,	NULL
p52	NULL
(	NULL
lanes	NULL
6	NULL
and	NULL
18	NULL
)	NULL
,	NULL
Tax	NULL
and	NULL
p100	NULL
(	NULL
lanes	NULL
7	NULL
and	NULL
19	NULL
)	NULL
,	NULL
TaxM22	NULL
and	NULL
p100	NULL
(	NULL
lanes	NULL
8	NULL
and	NULL
20	NULL
)	NULL
,	NULL
TaxM47	NULL
and	NULL
p100	NULL
(	NULL
lanes	NULL
9	NULL
and	NULL
21	NULL
)	NULL
,	NULL
Tax	NULL
and	NULL
p52	NULL
(	NULL
lanes	NULL
10	NULL
and	NULL
22	NULL
)	NULL
,	NULL
TaxM22	NULL
and	NULL
p52	NULL
(	NULL
lanes	NULL
11	NULL
and	NULL
23	NULL
)	NULL
,	NULL
or	NULL
TaxM47	NULL
and	NULL
p52	NULL
(	NULL
lanes	NULL
12	NULL
and	NULL
24	NULL
)	NULL
.	NULL

The	NULL
corresponding	NULL
radiolabeled	NULL
extracts	NULL
were	NULL
subjected	NULL
to	NULL
immunoprecipitation	NULL
with	NULL
the	NULL
anti-Tax	NULL
antiserum	NULL
(	NULL
lanes	NULL
1	NULL
to	NULL
12	NULL
)	NULL
or	NULL
the	NULL
anti-p100	NULL
antiserum	NULL
(	NULL
lanes	NULL
13	NULL
to	NULL
24	NULL
)	NULL
.	NULL

p100	NULL
,	NULL
p52	NULL
,	NULL
and	NULL
Tax	NULL
proteins	NULL
are	NULL
identified	NULL
.	NULL

formed	NULL
with	NULL
an	NULL
antiserum	NULL
specific	NULL
for	NULL
the	NULL
N-terminal	NULL
region	NULL
__	NULL
with	NULL
both	NULL
Tax	NULL
and	NULL
p105	NULL
expression	NULL
vectors	NULL
revealed	NULL
the	NULL
of	NULL
p100	NULL
.	NULL

Consistent	NULL
with	NULL
results	NULL
obtained	NULL
with	NULL
use	NULL
of	NULL
anti-Tax	NULL
,	NULL
Tax	NULL
was	NULL
coimmunoprecipitated	NULL
with	NULL
both	NULL
p100	NULL
(	NULL
lane	NULL
11	NULL
)	NULL
and	NULL
p52	NULL
(	NULL
lane	NULL
12	NULL
)	NULL
,	NULL
although	NULL
the	NULL
overall	NULL
level	NULL
of	NULL
Tax	NULL
recovery	NULL
was	NULL
less	NULL
than	NULL
the	NULL
amounts	NULL
of	NULL
p100	NULL
and	NULL
p52	NULL
recovered	NULL
in	NULL
the	NULL
anti-Tax	NULL
immunoprecipitation	NULL
experiment	NULL
.	NULL

Together	NULL
,	NULL
these	NULL
findings	NULL
demonstrate	NULL
that	NULL
Tax	NULL
physically	NULL
interacts	NULL
with	NULL
the	NULL
NF-kB2	NULL
precursor	NULL
gene	NULL
product	NULL
p100	NULL
and	NULL
its	NULL
processed	NULL
p52	NULL
counterpart	NULL
.	NULL

Tax	NULL
interacts	NULL
very	NULL
weakly	NULL
with	NULL
p105	NULL
compared	NULL
with	NULL
p100	NULL
.	NULL

Hirai	NULL
et	NULL
al	NULL
.	NULL

(	NULL
40	NULL
)	NULL
have	NULL
recently	NULL
reported	NULL
that	NULL
Tax	NULL
physically	NULL
interacts	NULL
with	NULL
p105	NULL
,	NULL
the	NULL
product	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B1	NULL
gene	NULL
and	NULL
precursor	NULL
of	NULL
the	NULL
p50	NULL
subunit	NULL
of	NULL
NF-kB	NULL
.	NULL

Coimmunoprecipitation	NULL
studies	NULL
were	NULL
next	NULL
performed	NULL
to	NULL
compare	NULL
the	NULL
p105-Tax	NULL
interaction	NULL
with	NULL
the	NULL
p100-Tax	NULL
interaction	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
.	NULL

Anti-Tax	NULL
immunoprecipitation	NULL
of	NULL
extracts	NULL
from	NULL
cells	NULL
cotransfected	NULL
presence	NULL
of	NULL
Tax	NULL
but	NULL
only	NULL
trace	NULL
amounts	NULL
of	NULL
p105	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
.	NULL

Similarly	NULL
,	NULL
using	NULL
a	NULL
p105-specific	NULL
antiserum	NULL
,	NULL
only	NULL
a	NULL
very	NULL
faint	NULL
band	NULL
corresponding	NULL
to	NULL
coimmunoprecipitated	NULL
Tax	NULL
was	NULL
detected	NULL
{	NULL
lane	NULL
8	NULL
)	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
the	NULL
interaction	NULL
of	NULL
Tax	NULL
with	NULL
p105	NULL
is	NULL
quite	NULL
weak	NULL
compared	NULL
with	NULL
the	NULL
interaction	NULL
observed	NULL
between	NULL
Tax	NULL
and	NULL
p100	NULL
.	NULL

Mutant	NULL
TaxM22	NULL
,	NULL
which	NULL
is	NULL
unable	NULL
to	NULL
activate	NULL
NF-B	NULL
,	NULL
interacts	NULL
poorly	NULL
with	NULL
p100	NULL
.	NULL

Previous	NULL
studies	NULL
have	NULL
resulted	NULL
in	NULL
the	NULL
identification	NULL
of	NULL
Tax	NULL
mutants	NULL
that	NULL
functionally	NULL
segregate	NULL
NF-	NULL
«	NULL
B/Rel-mediated	NULL
transactivation	NULL
of	NULL
the	NULL
HIV-1	NULL
LTR	NULL
(	NULL
NF-	NULL
«	NULL
kB	NULL
)	NULL
from	NULL
CREB/ATF/HEB-l-mediated	NULL
activation	NULL
of	NULL
the	NULL
HTLV-I	NULL
LTR	NULL
(	NULL
71	NULL
)	NULL
.	NULL

Specifically	NULL
,	NULL
mutant	NULL
TaxM22	NULL
(	NULL
Gly	NULL
Leu-Ala	NULL
Ser	NULL
at	NULL
residues	NULL
137	NULL
and	NULL
138	NULL
)	NULL
lacks	NULL
the	NULL
ability	NULL
to	NULL
activate	NULL
the	NULL
HIV-1	NULL
LTR	NULL
yet	NULL
is	NULL
fully	NULL
functional	NULL
with	NULL
respect	NULL
to	NULL
activation	NULL
of	NULL
the	NULL
HTLV-I	NULL
promoter	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
mutant	NULL
Vor	NULL
.	NULL

14	NULL
,	NULL
1994	NULL
C8166	NULL
CE	NULL
C8166	NULL
CE	NULL
|	NULL
ones	NULL
r=	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
=	NULL
®	NULL
Lal	NULL
I	NULL
5	NULL
--	NULL
Tax	NULL
E1	NULL
C	NULL
AA	NULL
X	NULL
LK	NULL
:	NULL
A	NULL
4	NULL
,	NULL
C	NULL
_	NULL
to	NULL
Ar	NULL
4	NULL
,	NULL
L_	NULL
L_	NULL
Immunoblot	NULL
:	NULL
_	NULL
a-p100	NULL
a-Tax	NULL
HUT102	NULL
CE	NULL
HUT102	NULL
CE	NULL
I	NULL
7	NULL
8	NULL
9	NULL
10	NULL
11	NULL
12	NULL
=	NULL
#	NULL
@	NULL
A-	NULL
|	NULL
I	NULL
a	NULL
ye	NULL
f	NULL
--	NULL
Tax	NULL
WA	NULL
kA	NULL
CA	NULL
.	NULL

4	NULL
,	NULL
t	NULL
IP	NULL
:	NULL
owoofbg	NULL
3p	NULL
4	NULL
,	NULL
L_	NULL
L_	NULL
]	NULL
Immunoblot	NULL
:	NULL
_	NULL
a-p100	NULL
a-Tax	NULL
FIG	NULL
.	NULL

2	NULL
.	NULL

Tax	NULL
associates	NULL
with	NULL
p100	NULL
in	NULL
HTLV-L-infected	NULL
T-cell	NULL
lines	NULL
.	NULL

Cytoplasmic	NULL
extracts	NULL
(	NULL
CE	NULL
;	NULL
400	NULL
ug	NULL
)	NULL
from	NULL
the	NULL
Tax-expressing	NULL
HTLV-I-infected	NULL
C8166	NULL
(	NULL
lanes	NULL
1	NULL
to	NULL
6	NULL
)	NULL
and	NULL
HUT1O2	NULL
(	NULL
lanes	NULL
7	NULL
to	NULL
12	NULL
)	NULL
cell	NULL
lines	NULL
were	NULL
prepared	NULL
and	NULL
subjected	NULL
to	NULL
immunoprecipitation	NULL
(	NULL
IP	NULL
)	NULL
with	NULL
either	NULL
preimmune	NULL
NRS	NULL
(	NULL
lanes	NULL
1	NULL
,	NULL
5	NULL
,	NULL
7	NULL
,	NULL
and	NULL
11	NULL
)	NULL
,	NULL
anti-Rex-specific	NULL
peptide	NULL
antibodies	NULL
specific	NULL
for	NULL
amino	NULL
acids	NULL
173	NULL
to	NULL
186	NULL
(	NULL
lanes	NULL
2	NULL
and	NULL
8	NULL
)	NULL
,	NULL
anti-p100	NULL
antiserum	NULL
(	NULL
lanes	NULL
3	NULL
and	NULL
9	NULL
)	NULL
,	NULL
or	NULL
anti-Tax	NULL
antibodies	NULL
(	NULL
lanes	NULL
4	NULL
,	NULL
6	NULL
,	NULL
10	NULL
,	NULL
and	NULL
12	NULL
)	NULL
.	NULL

The	NULL
immunoprecipitates	NULL
were	NULL
then	NULL
electrophoresed	NULL
on	NULL
SDS-9	NULL
%	NULL
polyacrylamide	NULL
gels	NULL
and	NULL
subjected	NULL
to	NULL
immunoblotting	NULL
with	NULL
the	NULL
anti-p100	NULL
antibodies	NULL
(	NULL
lanes	NULL
1	NULL
to	NULL
4	NULL
and	NULL
7	NULL
to	NULL
10	NULL
)	NULL
or	NULL
the	NULL
anti-T	NULL
ax	NULL
antibodies	NULL
(	NULL
lanes	NULL
5	NULL
,	NULL
6	NULL
,	NULL
11	NULL
,	NULL
and	NULL
12	NULL
)	NULL
,	NULL
using	NULL
the	NULL
enhanced	NULL
chemilumi-nescence	NULL
system	NULL
.	NULL

Migration	NULL
of	NULL
the	NULL
p100	NULL
and	NULL
Tax	NULL
proteins	NULL
is	NULL
indi-cated	NULL
.	NULL

Ig	NULL
,	NULL
immunoglobulin	NULL
.	NULL

TaxM47	NULL
(	NULL
Leu	NULL
Leu-	NULL
Arg	NULL
Ser	NULL
at	NULL
residues	NULL
319	NULL
and	NULL
320	NULL
)	NULL
fails	NULL
to	NULL
activate	NULL
the	NULL
HTLV-I	NULL
promoter	NULL
but	NULL
retains	NULL
the	NULL
capacity	NULL
to	NULL
stimulate	NULL
the	NULL
HIV-1	NULL
LTR	NULL
.	NULL

In	NULL
light	NULL
of	NULL
these	NULL
distinct	NULL
pheno-typic	NULL
properties	NULL
,	NULL
we	NULL
next	NULL
tested	NULL
each	NULL
Tax	NULL
mutant	NULL
for	NULL
its	NULL
ability	NULL
to	NULL
interact	NULL
with	NULL
p100	NULL
(	NULL
Fig	NULL
.	NULL

1C	NULL
)	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
lanes	NULL
8	NULL
and	NULL
11	NULL
,	NULL
TaxM22	NULL
only	NULL
weakly	NULL
associated	NULL
with	NULL
p100	NULL
or	NULL
p52	NULL
,	NULL
respectively	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
as	NULL
shown	NULL
in	NULL
lanes	NULL
9	NULL
and	NULL
12	NULL
,	NULL
TaxM47	NULL
interacted	NULL
strongly	NULL
with	NULL
p100	NULL
and	NULL
p52	NULL
in	NULL
a	NULL
manner	NULL
similar	NULL
to	NULL
that	NULL
found	NULL
for	NULL
the	NULL
wild-type	NULL
Tax	NULL
protein	NULL
(	NULL
lanes	NULL
7	NULL
and	NULL
10	NULL
)	NULL
.	NULL

TaxM22	NULL
was	NULL
only	NULL
weakly	NULL
coimmunoprecipitated	NULL
with	NULL
p100	NULL
(	NULL
lane	NULL
20	NULL
)	NULL
or	NULL
p52	NULL
(	NULL
lane	NULL
23	NULL
)	NULL
when	NULL
anti-p100	NULL
antiserum	NULL
was	NULL
used	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
TaxM47	NULL
was	NULL
readily	NULL
coimmunoprecipitated	NULL
by	NULL
the	NULL
anti-p100	NULL
antibody	NULL
(	NULL
compare	NULL
lanes	NULL
21	NULL
and	NULL
24	NULL
with	NULL
lanes	NULL
19	NULL
and	NULL
22	NULL
)	NULL
.	NULL

These	NULL
coimmunoprecipitation	NULL
studies	NULL
thus	NULL
indicate	NULL
that	NULL
the	NULL
Tax-p100	NULL
interaction	NULL
is	NULL
quite	NULL
specific	NULL
,	NULL
since	NULL
a	NULL
missense	NULL
mutation	NULL
affecting	NULL
only	NULL
two	NULL
residues	NULL
in	NULL
the	NULL
primary	NULL
sequence	NULL
of	NULL
Tax	NULL
appears	NULL
to	NULL
markedly	NULL
impair	NULL
this	NULL
interaction	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
the	NULL
finding	NULL
that	NULL
TaxM22	NULL
both	NULL
fails	NULL
to	NULL
activate	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
only	NULL
weakly	NULL
interacts	NULL
with	NULL
p100	NULL
suggests	NULL
that	NULL
this	NULL
interaction	NULL
may	NULL
be	NULL
functionally	NULL
important	NULL
in	NULL
the	NULL
mechanism	NULL
by	NULL
which	NULL
Tax	NULL
deregulates	NULL
the	NULL
normally	NULL
inducible	NULL
pattern	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
expression	NULL
in	NULL
CD4	NULL
T	NULL
cells	NULL
.	NULL

Tax	NULL
is	NULL
physically	NULL
associated	NULL
with	NULL
p100	NULL
in	NULL
HTLV-l-infected	NULL
T-cell	NULL
lines	NULL
.	NULL

To	NULL
ensure	NULL
that	NULL
the	NULL
Tax-p100	NULL
interaction	NULL
detected	NULL
in	NULL
transfected	NULL
COS	NULL
cells	NULL
was	NULL
not	NULL
an	NULL
artifact	NULL
of	NULL
the	NULL
overex-pression	NULL
conditions	NULL
,	NULL
two	NULL
Tax-expressing	NULL
HTLV-I-infected	NULL
T-cell	NULL
lines	NULL
were	NULL
used	NULL
for	NULL
coimmunoprecipitation	NULL
studies	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

Cytoplasmic	NULL
extracts	NULL
prepared	NULL
from	NULL
C8166	NULL
or	NULL
HTLV-I	NULL
Tax	NULL
IS	NULL
REGULATED	NULL
BY	NULL
NF-	NULL
«	NULL
B	NULL
p100	NULL
1377	NULL
HUTIO2	NULL
cell	NULL
lines	NULL
were	NULL
immunoprecipitated	NULL
with	NULL
NRS	NULL
or	NULL
with	NULL
anti-Rex	NULL
,	NULL
anti-p100	NULL
,	NULL
or	NULL
anti-Tax	NULL
serum	NULL
and	NULL
then	NULL
immunoblotted	NULL
with	NULL
p100-specific	NULL
antiserum	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
lanes	NULL
4	NULL
and	NULL
10	NULL
,	NULL
a	NULL
band	NULL
comigrating	NULL
with	NULL
p100	NULL
was	NULL
coprecipitated	NULL
with	NULL
anti-Tax	NULL
from	NULL
both	NULL
the	NULL
C8166	NULL
and	NULL
the	NULL
HUT1O2	NULL
extracts	NULL
but	NULL
not	NULL
with	NULL
either	NULL
NRS	NULL
(	NULL
lanes	NULL
1	NULL
and	NULL
7	NULL
)	NULL
or	NULL
anti-Rex	NULL
(	NULL
lanes	NULL
2	NULL
and	NULL
8	NULL
)	NULL
.	NULL

Of	NULL
note	NULL
,	NULL
the	NULL
amount	NULL
of	NULL
p100	NULL
coprecipitated	NULL
with	NULL
Tax	NULL
in	NULL
HTLV-L-infected	NULL
cells	NULL
appeared	NULL
significantly	NULL
less	NULL
than	NULL
that	NULL
observed	NULL
in	NULL
extracts	NULL
from	NULL
transfected	NULL
COS	NULL
cells	NULL
.	NULL

This	NULL
finding	NULL
could	NULL
suggest	NULL
that	NULL
the	NULL
interaction	NULL
between	NULL
Tax	NULL
and	NULL
p100	NULL
in	NULL
these	NULL
cell	NULL
lines	NULL
is	NULL
comparably	NULL
weaker	NULL
;	NULL
however	NULL
,	NULL
this	NULL
difference	NULL
likely	NULL
reflects	NULL
higher	NULL
steady-state	NULL
levels	NULL
of	NULL
the	NULL
p100	NULL
protein	NULL
in	NULL
transfected	NULL
COS	NULL
cells	NULL
compared	NULL
with	NULL
the	NULL
levels	NULL
of	NULL
endogenous	NULL
p100	NULL
protein	NULL
in	NULL
the	NULL
HTLV-I-infected	NULL
cell	NULL
lines	NULL
.	NULL

The	NULL
expression	NULL
of	NULL
Tax	NULL
in	NULL
the	NULL
C8166	NULL
and	NULL
HUT1O2	NULL
cytoplasmic	NULL
extracts	NULL
was	NULL
confirmed	NULL
by	NULL
submitting	NULL
the	NULL
immunoprecipitates	NULL
to	NULL
immunoblotting	NULL
with	NULL
anti-Tax	NULL
antiserum	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
lanes	NULL
6	NULL
and	NULL
12	NULL
,	NULL
a	NULL
band	NULL
corresponding	NULL
to	NULL
Tax	NULL
was	NULL
precipitated	NULL
with	NULL
anti-Tax	NULL
from	NULL
both	NULL
the	NULL
C8166	NULL
and	NULL
HUT1O2	NULL
cytoplasmic	NULL
extracts	NULL
.	NULL

p100	NULL
inhibits	NULL
Tax-induced	NULL
activation	NULL
of	NULL
the	NULL
HTLV-I	NULL
LTR	NULL
.	NULL

To	NULL
assess	NULL
the	NULL
functional	NULL
consequences	NULL
of	NULL
the	NULL
interaction	NULL
of	NULL
p100	NULL
and	NULL
Tax	NULL
,	NULL
the	NULL
effect	NULL
of	NULL
coexpression	NULL
of	NULL
p100	NULL
on	NULL
Tax-mediated	NULL
activation	NULL
of	NULL
the	NULL
HTLV-I	NULL
LTR	NULL
was	NULL
studied	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

3	NULL
,	NULL
p100	NULL
produced	NULL
dose-dependent	NULL
inhibition	NULL
of	NULL
Tax-induced	NULL
stimulation	NULL
of	NULL
the	NULL
HTLV-I	NULL
LTR-CAT	NULL
reporter	NULL
plasmid	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
coexpression	NULL
of	NULL
Tax	NULL
and	NULL
p52	NULL
did	NULL
not	NULL
lead	NULL
to	NULL
inhibition	NULL
of	NULL
Tax	NULL
activation	NULL
of	NULL
the	NULL
HTLV-I	NULL
LTR	NULL
even	NULL
though	NULL
p52	NULL
and	NULL
Tax	NULL
readily	NULL
interact	NULL
with	NULL
each	NULL
other	NULL
.	NULL

Consistent	NULL
with	NULL
the	NULL
weak	NULL
association	NULL
observed	NULL
between	NULL
p105	NULL
and	NULL
Tax	NULL
,	NULL
p105	NULL
failed	NULL
to	NULL
alter	NULL
Tax	NULL
activation	NULL
of	NULL
the	NULL
HTLV-I	NULL
LTR	NULL
.	NULL

The	NULL
effects	NULL
of	NULL
p100	NULL
on	NULL
Tax-induced	NULL
activation	NULL
of	NULL
the	NULL
HIV-1	NULL
«	NULL
B	NULL
enhancer	NULL
were	NULL
similarly	NULL
studied	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
Tax	NULL
alone	NULL
produced	NULL
>	NULL
350-fold	NULL
activation	NULL
of	NULL
the	NULL
kB	NULL
enhancer	NULL
element	NULL
,	NULL
while	NULL
p100	NULL
,	NULL
p105	NULL
,	NULL
and	NULL
IxB	NULL
alone	NULL
were	NULL
without	NULL
effect	NULL
.	NULL

Cotransfection	NULL
of	NULL
Jurkat	NULL
T	NULL
cells	NULL
with	NULL
combinations	NULL
of	NULL
Tax	NULL
and	NULL
p100	NULL
inhibited	NULL
Tax-induced	NULL
activation	NULL
,	NULL
as	NULL
did	NULL
cotransfection	NULL
of	NULL
IxBa	NULL
.	NULL

Of	NULL
note	NULL
,	NULL
p100	NULL
was	NULL
consistently	NULL
more	NULL
effective	NULL
in	NULL
inhibiting	NULL
Tax-mediated	NULL
activation	NULL
of	NULL
the	NULL
HIV-1	NULL
LTR	NULL
(	NULL
80	NULL
%	NULL
inhibition	NULL
at	NULL
a	NULL
ratio	NULL
of	NULL
1:1	NULL
)	NULL
than	NULL
the	NULL
HTLV-I	NULL
LTR	NULL
(	NULL
25	NULL
%	NULL
at	NULL
a	NULL
ratio	NULL
of	NULL
1:4	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
p105	NULL
exerted	NULL
only	NULL
weak	NULL
inhibitory	NULL
effects	NULL
on	NULL
Tax	NULL
.	NULL

Similarly	NULL
,	NULL
the	NULL
same	NULL
inhibitory	NULL
effects	NULL
of	NULL
p100	NULL
were	NULL
observed	NULL
for	NULL
p65-mediated	NULL
induction	NULL
of	NULL
the	NULL
HIV-1	NULL
«	NULL
kB	NULL
enhancer	NULL
(	NULL
52	NULL
,	NULL
80	NULL
)	NULL
.	NULL

These	NULL
data	NULL
raise	NULL
the	NULL
possibility	NULL
that	NULL
this	NULL
inhibition	NULL
of	NULL
p65	NULL
function	NULL
could	NULL
contribute	NULL
to	NULL
the	NULL
p100	NULL
inhibitory	NULL
effect	NULL
on	NULL
Tax-mediated	NULL
activation	NULL
of	NULL
the	NULL
HIV-1	NULL
«	NULL
B	NULL
enhancer	NULL
element	NULL
.	NULL

p100	NULL
alters	NULL
the	NULL
subcellular	NULL
pattern	NULL
of	NULL
Tax	NULL
expression	NULL
.	NULL

HTLV-I	NULL
Tax	NULL
has	NULL
been	NULL
described	NULL
as	NULL
principally	NULL
a	NULL
nuclear	NULL
protein	NULL
that	NULL
contains	NULL
a	NULL
unique	NULL
nuclear	NULL
localization	NULL
signal	NULL
(	NULL
74	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
expression	NULL
of	NULL
p100	NULL
is	NULL
restricted	NULL
to	NULL
the	NULL
cytoplasmic	NULL
compartment	NULL
(	NULL
52	NULL
)	NULL
.	NULL

Indirect	NULL
immunoffluores-cence	NULL
studies	NULL
were	NULL
next	NULL
performed	NULL
to	NULL
assess	NULL
the	NULL
effects	NULL
of	NULL
coexpression	NULL
of	NULL
p100	NULL
on	NULL
the	NULL
subcellular	NULL
distribution	NULL
of	NULL
Tax	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

5	NULL
,	NULL
expression	NULL
of	NULL
Tax	NULL
alone	NULL
revealed	NULL
a	NULL
predominantly	NULL
nuclear	NULL
pattern	NULL
of	NULL
anti-Tax	NULL
staining	NULL
,	NULL
whereas	NULL
coexpression	NULL
of	NULL
p100	NULL
and	NULL
Tax	NULL
led	NULL
to	NULL
a	NULL
cytoplasmic	NULL
pattern	NULL
of	NULL
expression	NULL
(	NULL
compare	NULL
Fig	NULL
.	NULL

5A	NULL
and	NULL
F	NULL
)	NULL
.	NULL

This	NULL
redistributed	NULL
pattern	NULL
of	NULL
expression	NULL
was	NULL
not	NULL
due	NULL
to	NULL
an	NULL
immunological	NULL
cross-reaction	NULL
of	NULL
the	NULL
anti-Tax	NULL
antibody	NULL
with	NULL
p100	NULL
,	NULL
since	NULL
cells	NULL
transfected	NULL
with	NULL
p100	NULL
alone	NULL
failed	NULL
to	NULL
show	NULL
any	NULL
fluorescence	NULL
(	NULL
Fig	NULL
.	NULL

5B	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
the	NULL
marked	NULL
subcellular	NULL
retargeting	NULL
effects	NULL
of	NULL
p100	NULL
,	NULL
neither	NULL
p52	NULL
nor	NULL
p105	NULL
altered	NULL
the	NULL
nuclear	NULL
pattern	NULL
of	NULL
Tax	NULL
expression	NULL
(	NULL
compare	NULL
Fig	NULL
.	NULL

5A	NULL
,	NULL
G	NULL
,	NULL
and	NULL
H	NULL
)	NULL
.	NULL

Localization	NULL
of	NULL
mutants	NULL
TaxM22	NULL
and	NULL
TaxM47	NULL
was	NULL
also	NULL
1378	NULL
BERAUD	NULL
ET	NULL
AL	NULL
.	NULL

Mor	NULL
.	NULL

CELL	NULL
.	NULL

BroL	NULL
.	NULL

70	NULL
B	NULL
tiv	NULL
:	NULL
urn-cat	NULL
60	NULL
|-50	NULL
|	NULL
40	NULL
|	NULL
30	NULL
|	NULL
Fold	NULL
Induction	NULL
20	NULL
10	NULL
|	NULL
n	NULL
an	NULL
m	NULL
Or	NULL
4	NULL
q	NULL
’	NULL
*	NULL
%	NULL
'	NULL
4	NULL
>	NULL
%	NULL
%	NULL
‘	NULL
bﬁh	NULL
,	NULL
p	NULL
7	NULL
aan	NULL
.	NULL

b	NULL
00	NULL
%	NULL
,	NULL
4	NULL
*	NULL
weir	NULL
?	NULL

?	NULL

?	NULL

ca	NULL
at	NULL
a	NULL
'	NULL
a	NULL
'	NULL
a	NULL
'	NULL
o	NULL
,	NULL
°¢°¢Qﬂb	NULL
FIG	NULL
.	NULL

3.	NULL
p100	NULL
inhibition	NULL
of	NULL
the	NULL
Tax-mediated	NULL
transcription	NULL
activation	NULL
of	NULL
the	NULL
HTLV-I	NULL
LTR	NULL
.	NULL

Human	NULL
Jurkat	NULL
T	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
the	NULL
indicated	NULL
plasmids	NULL
together	NULL
with	NULL
0.5	NULL
ug	NULL
of	NULL
a	NULL
CAT	NULL
reporter	NULL
plasmid	NULL
containing	NULL
the	NULL
HTLV-I	NULL
LTR	NULL
(	NULL
75	NULL
)	NULL
.	NULL

A	NULL
0.5-pg	NULL
amount	NULL
of	NULL
the	NULL
Tax-expressing	NULL
plasmid	NULL
was	NULL
used	NULL
,	NULL
and	NULL
the	NULL
numbers	NULL
following	NULL
the	NULL
slash	NULL
signs	NULL
represent	NULL
the	NULL
amounts	NULL
in	NULL
micrograms	NULL
of	NULL
p100-	NULL
,	NULL
p52-	NULL
,	NULL
and	NULL
pl0S-expressing	NULL
plasmids	NULL
used	NULL
.	NULL

CAT	NULL
activities	NULL
,	NULL
measured	NULL
approximately	NULL
40	NULL
h	NULL
after	NULL
transfection	NULL
,	NULL
are	NULL
presented	NULL
as	NULL
the	NULL
relative	NULL
fold	NULL
induction	NULL
over	NULL
the	NULL
basal	NULL
level	NULL
obtained	NULL
with	NULL
the	NULL
parental	NULL
pCMV4	NULL
expression	NULL
vector	NULL
.	NULL

The	NULL
data	NULL
shown	NULL
are	NULL
representative	NULL
of	NULL
a	NULL
single	NULL
experiment	NULL
;	NULL
however	NULL
,	NULL
four	NULL
independent	NULL
CAT	NULL
assays	NULL
were	NULL
performed	NULL
and	NULL
showed	NULL
the	NULL
same	NULL
inhibition	NULL
of	NULL
Tax	NULL
responsiveness	NULL
by	NULL
p100	NULL
.	NULL

studied	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
p100	NULL
.	NULL

Consistent	NULL
with	NULL
the	NULL
weak	NULL
association	NULL
of	NULL
TaxM22	NULL
and	NULL
p100	NULL
(	NULL
Fig	NULL
.	NULL

1C	NULL
)	NULL
,	NULL
TaxM22	NULL
remained	NULL
nuclear	NULL
(	NULL
compare	NULL
Fig	NULL
.	NULL

5D	NULL
and	NULL
I	NULL
)	NULL
,	NULL
while	NULL
TaxM47	NULL
,	NULL
which	NULL
effectively	NULL
binds	NULL
to	NULL
p100	NULL
,	NULL
was	NULL
retargeted	NULL
to	NULL
the	NULL
cytoplasm	NULL
(	NULL
compare	NULL
Fig	NULL
.	NULL

5E	NULL
and	NULL
J	NULL
)	NULL
.	NULL

Using	NULL
antisera	NULL
directed	NULL
against	NULL
p100	NULL
and	NULL
p105	NULL
,	NULL
we	NULL
controlled	NULL
that	NULL
p100	NULL
(	NULL
Fig	NULL
.	NULL

5K	NULL
,	NULL
N	NULL
,	NULL
and	NULL
O	NULL
)	NULL
,	NULL
p52	NULL
(	NULL
Fig	NULL
.	NULL

5L	NULL
)	NULL
,	NULL
and	NULL
p105	NULL
(	NULL
Fig	NULL
.	NULL

5M	NULL
)	NULL
were	NULL
readily	NULL
expressed	NULL
in	NULL
the	NULL
coexpression	NULL
experiments	NULL
.	NULL

400	NULL
xB-TATA-CAT	NULL
200|-	NULL
Fold	NULL
Induction	NULL
100-	NULL
35°34	NULL
\	NULL
*	NULL
%	NULL
``	NULL
3	NULL
%	NULL
*	NULL
%	NULL
*a	NULL
42	NULL
%	NULL
42808	NULL
,	NULL
``	NULL
Ao	NULL
°	NULL
4	NULL
aA	NULL
*	NULL
%	NULL
``	NULL
%	NULL
%	NULL
2	NULL
FIG	NULL
.	NULL

4.	NULL
p100	NULL
inhibition	NULL
of	NULL
the	NULL
Tax-mediated	NULL
transcriptional	NULL
activation	NULL
of	NULL
the	NULL
HIV-1	NULL
«	NULL
B	NULL
enhancer	NULL
.	NULL

Human	NULL
Jurkat	NULL
T	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
2	NULL
pg	NULL
of	NULL
the	NULL
indicated	NULL
plasmids	NULL
together	NULL
with	NULL
2	NULL
pg	NULL
of	NULL
a	NULL
CAT	NULL
reporter	NULL
plasmid	NULL
containing	NULL
the	NULL
HIV-1	NULL
«	NULL
B	NULL
enhancer	NULL
(	NULL
«	NULL
B-TATA-CAT	NULL
)	NULL
(	NULL
76	NULL
)	NULL
.	NULL

CAT	NULL
activities	NULL
,	NULL
measured	NULL
approximately	NULL
40	NULL
h	NULL
after	NULL
transfection	NULL
,	NULL
are	NULL
presented	NULL
as	NULL
the	NULL
relative	NULL
fold	NULL
induction	NULL
over	NULL
the	NULL
basal	NULL
level	NULL
obtained	NULL
with	NULL
the	NULL
parental	NULL
pCMV4	NULL
expression	NULL
vector	NULL
.	NULL

The	NULL
data	NULL
shown	NULL
are	NULL
representative	NULL
of	NULL
a	NULL
single	NULL
experiment	NULL
;	NULL
however	NULL
,	NULL
three	NULL
independent	NULL
experiments	NULL
were	NULL
performed	NULL
and	NULL
showed	NULL
the	NULL
same	NULL
results	NULL
.	NULL

DISCUSSION	NULL
In	NULL
this	NULL
report	NULL
,	NULL
we	NULL
provide	NULL
evidence	NULL
for	NULL
a	NULL
physical	NULL
and	NULL
functional	NULL
interaction	NULL
between	NULL
the	NULL
HTLV-I	NULL
Tax	NULL
transactivator	NULL
and	NULL
p100	NULL
,	NULL
the	NULL
Rel-related	NULL
product	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B2	NULL
gene	NULL
.	NULL

This	NULL
interaction	NULL
is	NULL
mediated	NULL
through	NULL
sequences	NULL
located	NULL
in	NULL
the	NULL
N-terminal	NULL
half	NULL
of	NULL
p100	NULL
since	NULL
p52	NULL
,	NULL
a	NULL
processed	NULL
form	NULL
of	NULL
p100	NULL
that	NULL
lacks	NULL
the	NULL
C-terminal	NULL
ankyrin	NULL
repeat	NULL
domain	NULL
,	NULL
retains	NULL
the	NULL
capacity	NULL
to	NULL
associate	NULL
with	NULL
Tax	NULL
.	NULL

This	NULL
interaction	NULL
of	NULL
Tax	NULL
and	NULL
p100	NULL
is	NULL
not	NULL
restricted	NULL
to	NULL
cells	NULL
transfected	NULL
with	NULL
Tax	NULL
and	NULL
p100	NULL
expression	NULL
vectors	NULL
but	NULL
has	NULL
also	NULL
been	NULL
detected	NULL
in	NULL
the	NULL
more	NULL
physiological	NULL
cellular	NULL
context	NULL
of	NULL
HTLV-I-infected	NULL
human	NULL
T-cell	NULL
lines	NULL
.	NULL

In	NULL
sharp	NULL
contrast	NULL
to	NULL
the	NULL
strong	NULL
p100-Tax	NULL
interaction	NULL
detected	NULL
in	NULL
these	NULL
coimmunoprecipitation	NULL
assays	NULL
,	NULL
only	NULL
a	NULL
very	NULL
weak	NULL
association	NULL
of	NULL
Tax	NULL
and	NULL
p105	NULL
,	NULL
the	NULL
product	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
xB1	NULL
gene	NULL
,	NULL
was	NULL
demonstrated	NULL
.	NULL

This	NULL
result	NULL
contrasts	NULL
with	NULL
the	NULL
prior	NULL
report	NULL
of	NULL
Hirai	NULL
and	NULL
colleagues	NULL
(	NULL
40	NULL
)	NULL
,	NULL
who	NULL
have	NULL
described	NULL
both	NULL
in	NULL
vitro	NULL
and	NULL
in	NULL
vivo	NULL
evidence	NULL
for	NULL
the	NULL
association	NULL
of	NULL
Tax	NULL
and	NULL
p105	NULL
;	NULL
p100	NULL
was	NULL
,	NULL
however	NULL
,	NULL
not	NULL
similarly	NULL
studied	NULL
.	NULL

The	NULL
bases	NULL
for	NULL
these	NULL
disparate	NULL
results	NULL
remain	NULL
unexplained	NULL
but	NULL
may	NULL
simply	NULL
reflect	NULL
differences	NULL
in	NULL
the	NULL
sensitivity	NULL
of	NULL
the	NULL
various	NULL
detection	NULL
assays	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
the	NULL
p105	NULL
expression	NULL
vector	NULL
used	NULL
in	NULL
our	NULL
studies	NULL
contains	NULL
wild-type	NULL
sequences	NULL
at	NULL
the	NULL
extreme	NULL
N	NULL
terminus	NULL
,	NULL
while	NULL
the	NULL
p105	NULL
vector	NULL
used	NULL
by	NULL
Hirai	NULL
and	NULL
coworkers	NULL
is	NULL
remarkable	NULL
for	NULL
a	NULL
deletion	NULL
within	NULL
this	NULL
region	NULL
.	NULL

Whether	NULL
this	NULL
difference	NULL
contributes	NULL
to	NULL
the	NULL
efficacy	NULL
of	NULL
p105	NULL
binding	NULL
to	NULL
Tax	NULL
remains	NULL
to	NULL
be	NULL
determined	NULL
.	NULL

Notwith-standing	NULL
,	NULL
it	NULL
is	NULL
clear	NULL
that	NULL
the	NULL
association	NULL
of	NULL
p100	NULL
with	NULL
Tax	NULL
is	NULL
far	NULL
stronger	NULL
than	NULL
that	NULL
observed	NULL
with	NULL
p105	NULL
.	NULL

More	NULL
importantly	NULL
,	NULL
no	NULL
functional	NULL
consequences	NULL
have	NULL
yet	NULL
been	NULL
attributed	NULL
to	NULL
the	NULL
p105-Tax	NULL
interaction	NULL
,	NULL
while	NULL
as	NULL
noted	NULL
below	NULL
,	NULL
the	NULL
formation	NULL
of	NULL
p100-Tax	NULL
complexes	NULL
leads	NULL
to	NULL
inhibition	NULL
of	NULL
Tax	NULL
function	NULL
.	NULL

These	NULL
findings	NULL
regarding	NULL
the	NULL
physical	NULL
interaction	NULL
of	NULL
Tax	NULL
with	NULL
the	NULL
Rel-related	NULL
p100	NULL
protein	NULL
extend	NULL
earlier	NULL
reports	NULL
regarding	NULL
the	NULL
physical	NULL
association	NULL
of	NULL
Tax	NULL
with	NULL
transcription	NULL
factors	NULL
such	NULL
as	NULL
members	NULL
of	NULL
the	NULL
CREB/ATF	NULL
family	NULL
and	NULL
HEB-1	NULL
(	NULL
9	NULL
,	NULL
81	NULL
,	NULL
89	NULL
,	NULL
90	NULL
)	NULL
.	NULL

These	NULL
cellular	NULL
proteins	NULL
directly	NULL
engage	NULL
Vor	NULL
.	NULL

14	NULL
,	NULL
1994	NULL
Tax	NULL
Anti-Tax	NULL
Tax	NULL
+	NULL
p100	NULL
Tax	NULL
+	NULL
p52	NULL
Anti-Tax	NULL
Tax	NULL
+	NULL
p100	NULL
Anti-p100	NULL
5:4	NULL
or	NULL
_	NULL
Anti-p105	NULL
L	NULL
Tax	NULL
+	NULL
p105	NULL
HTLV-I	NULL
Tax	NULL
IS	NULL
REGULATED	NULL
BY	NULL
NF-	NULL
«	NULL
B	NULL
p100	NULL
1379	NULL
Tax	NULL
M22	NULL
Tax	NULL
M47	NULL
p105	NULL
Tax	NULL
M47	NULL
+	NULL
p100	NULL
FIG	NULL
.	NULL

5	NULL
.	NULL

Subcellular	NULL
localization	NULL
of	NULL
Tax	NULL
in	NULL
the	NULL
presence	NULL
and	NULL
absence	NULL
of	NULL
p100	NULL
.	NULL

COS-7	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
Tax	NULL
(	NULL
A	NULL
)	NULL
,	NULL
p100	NULL
(	NULL
B	NULL
)	NULL
,	NULL
p105	NULL
(	NULL
C	NULL
)	NULL
,	NULL
TaxM22	NULL
(	NULL
D	NULL
)	NULL
,	NULL
TaxM47	NULL
(	NULL
E	NULL
)	NULL
,	NULL
Tax	NULL
plus	NULL
p100	NULL
(	NULL
F	NULL
and	NULL
K	NULL
)	NULL
,	NULL
Tax	NULL
plus	NULL
p52	NULL
(	NULL
G	NULL
and	NULL
L	NULL
)	NULL
,	NULL
Tax	NULL
plus	NULL
p105	NULL
(	NULL
H	NULL
and	NULL
M	NULL
)	NULL
,	NULL
TaxM22	NULL
plus	NULL
p100	NULL
(	NULL
I	NULL
and	NULL
N	NULL
)	NULL
,	NULL
or	NULL
TaxM47	NULL
plus	NULL
p100	NULL
(	NULL
J	NULL
and	NULL
O	NULL
)	NULL
.	NULL

After	NULL
48	NULL
h	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
fixed	NULL
,	NULL
incubated	NULL
with	NULL
the	NULL
antiserum	NULL
specific	NULL
for	NULL
the	NULL
C	NULL
terminus	NULL
of	NULL
Tax	NULL
(	NULL
A	NULL
to	NULL
J	NULL
)	NULL
,	NULL
the	NULL
N	NULL
terminus	NULL
of	NULL
p100	NULL
(	NULL
K	NULL
,	NULL
L	NULL
,	NULL
N	NULL
,	NULL
and	NULL
O	NULL
)	NULL
,	NULL
or	NULL
the	NULL
N	NULL
terminus	NULL
of	NULL
p105	NULL
(	NULL
M	NULL
)	NULL
and	NULL
then	NULL
subjected	NULL
to	NULL
indirect	NULL
immunofluorescence	NULL
staining	NULL
using	NULL
Texas	NULL
red-conjugated	NULL
anti-rabbit	NULL
immunoglobulins	NULL
.	NULL

the	NULL
three	NULL
21-bp	NULL
repeats	NULL
present	NULL
in	NULL
the	NULL
HTLV-I	NULL
LTR	NULL
.	NULL

Pre-sumably	NULL
,	NULL
the	NULL
indirect	NULL
tethering	NULL
of	NULL
Tax	NULL
to	NULL
these	NULL
factors	NULL
endows	NULL
this	NULL
complex	NULL
with	NULL
unique	NULL
functional	NULL
properties	NULL
that	NULL
underly	NULL
Tax-mediated	NULL
transactivation	NULL
of	NULL
the	NULL
HTLV-I	NULL
LTR	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
Tax-CREB/HEB-1	NULL
,	NULL
studies	NULL
of	NULL
the	NULL
p100-Tax	NULL
interaction	NULL
have	NULL
revealed	NULL
a	NULL
very	NULL
different	NULL
functional	NULL
conse-quence	NULL
.	NULL

Indeed	NULL
,	NULL
the	NULL
association	NULL
of	NULL
Tax	NULL
with	NULL
p100	NULL
leads	NULL
to	NULL
the	NULL
marked	NULL
inhibition	NULL
of	NULL
Tax-induced	NULL
activation	NULL
of	NULL
both	NULL
the	NULL
HTLV-I	NULL
LTR	NULL
and	NULL
the	NULL
HIV-1	NULL
«	NULL
B	NULL
enhancer	NULL
.	NULL

The	NULL
dose-response	NULL
difference	NULL
observed	NULL
for	NULL
p100	NULL
inhibition	NULL
of	NULL
Tax-mediated	NULL
activation	NULL
of	NULL
the	NULL
HTLV-I	NULL
LTR	NULL
versus	NULL
the	NULL
HIV-1	NULL
LTR	NULL
may	NULL
stem	NULL
from	NULL
differences	NULL
in	NULL
the	NULL
sensitivity	NULL
of	NULL
these	NULL
two	NULL
promoters	NULL
to	NULL
the	NULL
HTLV-I	NULL
Tax	NULL
protein	NULL
.	NULL

Specifically	NULL
,	NULL
the	NULL
HTLV-I	NULL
LTR	NULL
may	NULL
respond	NULL
well	NULL
at	NULL
lower	NULL
concentrations	NULL
of	NULL
Tax	NULL
.	NULL

As	NULL
judged	NULL
from	NULL
results	NULL
from	NULL
indirect	NULL
immunofluorescence	NULL
studies	NULL
,	NULL
this	NULL
inhibition	NULL
by	NULL
p100	NULL
is	NULL
correlated	NULL
with	NULL
retargeting	NULL
of	NULL
Tax	NULL
expression	NULL
from	NULL
the	NULL
nuclear	NULL
to	NULL
the	NULL
cytoplasmic	NULL
compartment	NULL
.	NULL

In	NULL
this	NULL
regard	NULL
,	NULL
these	NULL
inhibitory	NULL
effects	NULL
of	NULL
the	NULL
cytoplasmic	NULL
p100	NULL
protein	NULL
are	NULL
not	NULL
recapitulated	NULL
by	NULL
p52	NULL
,	NULL
which	NULL
when	NULL
expressed	NULL
alone	NULL
accumulates	NULL
in	NULL
the	NULL
nucleus	NULL
.	NULL

These	NULL
findings	NULL
suggest	NULL
that	NULL
the	NULL
C-terminal	NULL
sequences	NULL
removed	NULL
in	NULL
the	NULL
processing	NULL
of	NULL
p100	NULL
to	NULL
p52	NULL
are	NULL
critical	NULL
for	NULL
functional	NULL
inhibition	NULL
of	NULL
Tax	NULL
and	NULL
retargeting	NULL
of	NULL
this	NULL
viral	NULL
transactivator	NULL
to	NULL
the	NULL
cytoplasm	NULL
.	NULL

These	NULL
deleted	NULL
sequences	NULL
are	NULL
notable	NULL
for	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
multiple	NULL
ankyrin	NULL
repeats	NULL
known	NULL
to	NULL
be	NULL
required	NULL
for	NULL
the	NULL
retention	NULL
of	NULL
p100	NULL
in	NULL
the	NULL
cytoplasm	NULL
(	NULL
52	NULL
)	NULL
.	NULL

These	NULL
ankyrin	NULL
repeats	NULL
also	NULL
play	NULL
a	NULL
critical	NULL
role	NULL
in	NULL
p100-mediated	NULL
inhibition	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
function	NULL
,	NULL
a	NULL
response	NULL
that	NULL
similarly	NULL
involves	NULL
cytoplasmic	NULL
sequestration	NULL
of	NULL
the	NULL
p65	NULL
subunit	NULL
(	NULL
52	NULL
,	NULL
80	NULL
)	NULL
.	NULL

Recent	NULL
studies	NULL
have	NULL
demonstrated	NULL
that	NULL
both	NULL
p100	NULL
and	NULL
p105	NULL
can	NULL
function	NULL
as	NULL
IxB-like	NULL
molecules	NULL
for	NULL
various	NULL
Rel	NULL
family	NULL
members	NULL
,	NULL
including	NULL
p65	NULL
and	NULL
c-Rel	NULL
(	NULL
52	NULL
,	NULL
55	NULL
,	NULL
63	NULL
,	NULL
80	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
p100	NULL
not	NULL
only	NULL
sequesters	NULL
Tax	NULL
in	NULL
the	NULL
cytoplasm	NULL
but	NULL
also	NULL
sequesters	NULL
p65	NULL
and	NULL
c-Rel	NULL
,	NULL
leading	NULL
to	NULL
the	NULL
inhibited	NULL
function	NULL
of	NULL
these	NULL
Rel-related	NULL
transcription	NULL
factors	NULL
.	NULL

.	NULL

NF-	NULL
«	NULL
B	NULL
p65	NULL
,	NULL
Tax	NULL
,	NULL
and	NULL
p100	NULL
are	NULL
also	NULL
functionally	NULL
linked	NULL
in	NULL
another	NULL
potentially	NULL
related	NULL
regulatory	NULL
pathway	NULL
.	NULL

Among	NULL
its	NULL
many	NULL
effects	NULL
,	NULL
Tax	NULL
expression	NULL
leads	NULL
to	NULL
the	NULL
activation	NULL
of	NULL
nuclear	NULL
NF-	NULL
«	NULL
B	NULL
expression	NULL
.	NULL

Our	NULL
recent	NULL
studies	NULL
demonstrate	NULL
that	NULL
the	NULL
p65	NULL
subunit	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
in	NULL
turn	NULL
stimulates	NULL
not	NULL
only	NULL
IxB-	NULL
«	NULL
expression	NULL
(	NULL
79	NULL
)	NULL
but	NULL
also	NULL
NF-	NULL
«	NULL
B2	NULL
gene	NULL
expression	NULL
,	NULL
leading	NULL
to	NULL
increased	NULL
p100	NULL
protein	NULL
levels	NULL
(	NULL
80	NULL
)	NULL
.	NULL

Similarly	NULL
,	NULL
two-to	NULL
threefold-higher	NULL
levels	NULL
of	NULL
p100	NULL
protein	NULL
and	NULL
NF-	NULL
«	NULL
B2	NULL
mRNA	NULL
are	NULL
detectable	NULL
in	NULL
Tax-expressing	NULL
ATL	NULL
cells	NULL
compared	NULL
with	NULL
ATL	NULL
cells	NULL
that	NULL
lack	NULL
this	NULL
retroviral	NULL
function	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
ensuing	NULL
binding	NULL
of	NULL
p100	NULL
to	NULL
both	NULL
Tax	NULL
and	NULL
p65	NULL
serves	NULL
to	NULL
down-regulate	NULL
the	NULL
functional	NULL
activity	NULL
of	NULL
each	NULL
,	NULL
thus	NULL
highlighting	NULL
a	NULL
negative	NULL
feedback	NULL
loop	NULL
involving	NULL
a	NULL
single	NULL
cytoplasmic	NULL
inhibitor	NULL
that	NULL
affects	NULL
both	NULL
Tax	NULL
and	NULL
p65	NULL
action	NULL
.	NULL

One	NULL
potential	NULL
implication	NULL
from	NULL
these	NULL
studies	NULL
is	NULL
that	NULL
the	NULL
observed	NULL
inhibitory	NULL
effects	NULL
of	NULL
p100	NULL
on	NULL
Tax-mediated	NULL
function	NULL
may	NULL
play	NULL
a	NULL
role	NULL
in	NULL
the	NULL
profound	NULL
state	NULL
of	NULL
viral	NULL
latency	NULL
characteristic	NULL
of	NULL
HTLV-I-infected	NULL
cells	NULL
in	NULL
vivo	NULL
.	NULL

Even	NULL
by	NULL
using	NULL
sensitive	NULL
approaches	NULL
involving	NULL
reverse	NULL
transcription	NULL
coupled	NULL
with	NULL
PCR	NULL
amplification	NULL
,	NULL
it	NULL
has	NULL
been	NULL
difficult	NULL
to	NULL
demonstrate	NULL
viral	NULL
RNA	NULL
expression	NULL
in	NULL
circulating	NULL
leukemic	NULL
T	NULL
cells	NULL
(	NULL
10	NULL
)	NULL
.	NULL

However	NULL
,	NULL
given	NULL
that	NULL
a	NULL
severalfold	NULL
excess	NULL
of	NULL
p100	NULL
appears	NULL
necessary	NULL
to	NULL
inhibit	NULL
Tax-mediated	NULL
activation	NULL
of	NULL
the	NULL
HTLV-I	NULL
LTR	NULL
,	NULL
this	NULL
effect	NULL
may	NULL
play	NULL
only	NULL
a	NULL
marginal	NULL
role	NULL
in	NULL
the	NULL
latency	NULL
associated	NULL
with	NULL
HTLV-I	NULL
infection	NULL
.	NULL

These	NULL
inhibitory	NULL
effects	NULL
of	NULL
p100	NULL
are	NULL
probably	NULL
only	NULL
one	NULL
of	NULL
the	NULL
mechanisms	NULL
responsible	NULL
for	NULL
the	NULL
viral	NULL
latency	NULL
;	NULL
however	NULL
,	NULL
we	NULL
believe	NULL
that	NULL
they	NULL
are	NULL
highly	NULL
significant	NULL
.	NULL

Indeed	NULL
,	NULL
transfected	NULL
cells	NULL
only	NULL
partially	NULL
reflect	NULL
what	NULL
occurs	NULL
in	NULL
the	NULL
infected	NULL
cells	NULL
and	NULL
particularly	NULL
the	NULL
very	NULL
tight	NULL
regulation	NULL
of	NULL
p100	NULL
expression	NULL
by	NULL
Tax	NULL
1380	NULL
BERAUD	NULL
ET	NULL
AL	NULL
.	NULL

itself	NULL
.	NULL

This	NULL
state	NULL
of	NULL
viral	NULL
latency	NULL
also	NULL
suggests	NULL
that	NULL
viral	NULL
gene	NULL
expression	NULL
is	NULL
not	NULL
necessary	NULL
for	NULL
maintenance	NULL
of	NULL
the	NULL
transformed	NULL
state	NULL
.	NULL

Rather	NULL
,	NULL
the	NULL
virus	NULL
might	NULL
have	NULL
played	NULL
its	NULL
pivotal	NULL
role	NULL
at	NULL
an	NULL
earlier	NULL
juncture	NULL
in	NULL
the	NULL
transformation	NULL
process	NULL
.	NULL

On	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
antibody	NULL
responses	NULL
to	NULL
Tax	NULL
and	NULL
other	NULL
viral	NULL
proteins	NULL
appear	NULL
to	NULL
persist	NULL
throughout	NULL
the	NULL
entire	NULL
period	NULL
of	NULL
clinical	NULL
latency	NULL
,	NULL
which	NULL
may	NULL
span	NULL
20	NULL
to	NULL
30	NULL
years	NULL
.	NULL

This	NULL
finding	NULL
suggests	NULL
that	NULL
viral	NULL
gene	NULL
expression	NULL
must	NULL
be	NULL
occurring	NULL
in	NULL
some	NULL
compartment	NULL
of	NULL
the	NULL
body	NULL
even	NULL
though	NULL
it	NULL
is	NULL
undetectable	NULL
in	NULL
the	NULL
circulating	NULL
leukemic	NULL
T	NULL
cells	NULL
.	NULL

It	NULL
is	NULL
possible	NULL
that	NULL
this	NULL
response	NULL
reflects	NULL
the	NULL
fine	NULL
regulation	NULL
of	NULL
viral	NULL
expression	NULL
controlled	NULL
by	NULL
the	NULL
inhibitory	NULL
effect	NULL
of	NULL
p100	NULL
on	NULL
Tax-mediated	NULL
activation	NULL
and	NULL
the	NULL
positive	NULL
effect	NULL
of	NULL
Tax	NULL
on	NULL
p100	NULL
expression	NULL
through	NULL
the	NULL
activation	NULL
of	NULL
p65	NULL
.	NULL

The	NULL
importance	NULL
of	NULL
the	NULL
interaction	NULL
between	NULL
p100	NULL
and	NULL
Tax	NULL
in	NULL
viral	NULL
latency	NULL
raises	NULL
the	NULL
question	NULL
of	NULL
what	NULL
percentage	NULL
of	NULL
Tax	NULL
is	NULL
associated	NULL
with	NULL
p100	NULL
in	NULL
HTLV-L-infected	NULL
cell	NULL
lines	NULL
.	NULL

Using	NULL
nuclear	NULL
and	NULL
cytoplasmic	NULL
extracts	NULL
,	NULL
we	NULL
have	NULL
observed	NULL
that	NULL
Tax	NULL
is	NULL
shared	NULL
equally	NULL
between	NULL
the	NULL
cytoplasm	NULL
and	NULL
the	NULL
nucleus	NULL
,	NULL
suggesting	NULL
that	NULL
only	NULL
half	NULL
of	NULL
the	NULL
protein	NULL
is	NULL
associated	NULL
with	NULL
p100	NULL
in	NULL
the	NULL
HTLV-I-infected	NULL
cells	NULL
.	NULL

However	NULL
,	NULL
these	NULL
experiments	NULL
do	NULL
not	NULL
take	NULL
into	NULL
account	NULL
the	NULL
remarkable	NULL
dynamics	NULL
of	NULL
Tax	NULL
production	NULL
and	NULL
transport	NULL
into	NULL
the	NULL
nucleus	NULL
versus	NULL
association	NULL
with	NULL
p100	NULL
in	NULL
the	NULL
cytoplasm	NULL
and	NULL
the	NULL
up-regulation	NULL
of	NULL
p100	NULL
production	NULL
by	NULL
Tax	NULL
.	NULL

While	NULL
this	NULL
present	NULL
study	NULL
clearly	NULL
demonstrates	NULL
that	NULL
the	NULL
interaction	NULL
between	NULL
Tax	NULL
and	NULL
p100	NULL
is	NULL
functional	NULL
,	NULL
the	NULL
observed	NULL
inhibitory	NULL
effects	NULL
of	NULL
p100	NULL
on	NULL
Tax	NULL
fail	NULL
to	NULL
provide	NULL
definitive	NULL
insights	NULL
into	NULL
the	NULL
mechanism	NULL
by	NULL
which	NULL
Tax	NULL
activates	NULL
nuclear	NULL
expression	NULL
of	NULL
members	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B/Rel	NULL
family	NULL
.	NULL

Specifically	NULL
,	NULL
our	NULL
finding	NULL
that	NULL
mutant	NULL
TaxM22	NULL
,	NULL
which	NULL
can	NULL
not	NULL
induce	NULL
NF-kB	NULL
expression	NULL
,	NULL
binds	NULL
only	NULL
weakly	NULL
to	NULL
p100	NULL
or	NULL
pS2	NULL
strongly	NULL
suggested	NULL
that	NULL
the	NULL
interaction	NULL
of	NULL
Tax	NULL
and	NULL
p100	NULL
or	NULL
pS2	NULL
might	NULL
be	NULL
critically	NULL
involved	NULL
in	NULL
the	NULL
induction	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

In	NULL
this	NULL
context	NULL
,	NULL
we	NULL
considered	NULL
several	NULL
mechanistic	NULL
explanations	NULL
including	NULL
,	NULL
that	NULL
(	NULL
i	NULL
)	NULL
Tax	NULL
binding	NULL
to	NULL
p100	NULL
might	NULL
accelerate	NULL
its	NULL
posttranslational	NULL
cleavage	NULL
to	NULL
p52	NULL
,	NULL
which	NULL
in	NULL
turn	NULL
facilitates	NULL
the	NULL
nuclear	NULL
expression	NULL
of	NULL
this	NULL
Rel	NULL
family	NULL
member	NULL
,	NULL
and	NULL
(	NULL
ii	NULL
)	NULL
Tax	NULL
binding	NULL
to	NULL
p100	NULL
inhibits	NULL
its	NULL
IxB-like	NULL
function	NULL
,	NULL
perhaps	NULL
by	NULL
releasing	NULL
p100	NULL
from	NULL
known	NULL
transactivating	NULL
subunits	NULL
such	NULL
as	NULL
p65	NULL
or	NULL
c-Rel	NULL
,	NULL
thereby	NULL
allowing	NULL
their	NULL
nuclear	NULL
import	NULL
.	NULL

Thus	NULL
far	NULL
,	NULL
however	NULL
,	NULL
we	NULL
have	NULL
been	NULL
unable	NULL
to	NULL
show	NULL
that	NULL
Tax	NULL
accelerates	NULL
p100	NULL
posttranscriptional	NULL
cleavage	NULL
to	NULL
p52	NULL
.	NULL

Furthermore	NULL
,	NULL
recent	NULL
in	NULL
vitro	NULL
studies	NULL
suggest	NULL
that	NULL
Tax	NULL
does	NULL
not	NULL
displace	NULL
p65	NULL
bound	NULL
to	NULL
p100	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

As	NULL
such	NULL
,	NULL
the	NULL
mechanism	NULL
by	NULL
which	NULL
Tax	NULL
induces	NULL
the	NULL
constitutive	NULL
nuclear	NULL
expression	NULL
of	NULL
NF-	NULL
«	NULL
B/Re	NULL
!	NULL

l	NULL
in	NULL
virally	NULL
infected	NULL
cells	NULL
remains	NULL
enigmatic	NULL
.	NULL

Not-withstanding	NULL
,	NULL
it	NULL
has	NULL
become	NULL
increasingly	NULL
clear	NULL
that	NULL
HTLV-I	NULL
Tax	NULL
participates	NULL
in	NULL
a	NULL
diverse	NULL
array	NULL
of	NULL
protein-protein	NULL
interactions	NULL
within	NULL
host	NULL
CD4	NULL
T	NULL
cells	NULL
,	NULL
some	NULL
of	NULL
which	NULL
potentiate	NULL
its	NULL
transcriptional	NULL
activating	NULL
properties	NULL
,	NULL
while	NULL
others	NULL
,	NULL
notably	NULL
its	NULL
binding	NULL
to	NULL
p100	NULL
,	NULL
appear	NULL
to	NULL
antagonize	NULL
its	NULL
biological	NULL
actions	NULL
.	NULL

ACKNOWLEDGMENTS	NULL
We	NULL
thank	NULL
A.	NULL
Israel	NULL
for	NULL
providing	NULL
the	NULL
p105	NULL
cDNA	NULL
,	NULL
G.	NULL
Nabel	NULL
for	NULL
the	NULL
p100	NULL
and	NULL
pS2	NULL
cDNAs	NULL
,	NULL
A.	NULL
Baldwin	NULL
for	NULL
the	NULL
human	NULL
IkBo/MAD-3	NULL
cDNA	NULL
,	NULL
C.	NULL
Rosen	NULL
for	NULL
the	NULL
human	NULL
p65	NULL
cDNA	NULL
,	NULL
and	NULL
Kathleen	NULL
Rafieses	NULL
for	NULL
preparation	NULL
of	NULL
the	NULL
manuscript	NULL
.	NULL

D.W.B	NULL
.	NULL

was	NULL
supported	NULL
by	NULL
the	NULL
Howard	NULL
Hughes	NULL
Medical	NULL
Institute	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Alexandre	NULL
,	NULL
C.	NULL
,	NULL
and	NULL
B.	NULL
Verrier	NULL
.	NULL

1991	NULL
.	NULL

Four	NULL
regulatory	NULL
elements	NULL
in	NULL
the	NULL
human	NULL
c-fos	NULL
promoter	NULL
mediate	NULL
transactivation	NULL
by	NULL
HTLV-I	NULL
Tax	NULL
protein	NULL
.	NULL

Oncogene	NULL
6:543-551	NULL
.	NULL

2	NULL
.	NULL

Andersson	NULL
,	NULL
S.	NULL
,	NULL
D.	NULL
Davis	NULL
,	NULL
H.	NULL
Dahlback	NULL
,	NULL
H.	NULL
Jornvall	NULL
,	NULL
and	NULL
K.	NULL
W.	NULL
Russell	NULL
.	NULL

1989	NULL
.	NULL

Cloning	NULL
,	NULL
structure	NULL
,	NULL
and	NULL
expression	NULL
of	NULL
the	NULL
mito-	NULL
10	NULL
.	NULL

11	NULL
.	NULL

12	NULL
.	NULL

13	NULL
.	NULL

14	NULL
.	NULL

15	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

Mor	NULL
.	NULL

CELL	NULL
.	NULL

BroL..	NULL
chondrial	NULL
cytochrome	NULL
P-450	NULL
sterol	NULL
26-hydroxylase	NULL
,	NULL
a	NULL
bile	NULL
acid	NULL
biosynthetic	NULL
enzyme	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

264:8222-8229.	NULL
.	NULL

Baeuerle	NULL
,	NULL
P.	NULL
A	NULL
.	NULL

1991	NULL
.	NULL

The	NULL
inducible	NULL
transcription	NULL
activator	NULL
NF-	NULL
«	NULL
B	NULL
:	NULL
regulation	NULL
by	NULL
distinct	NULL
protein	NULL
subunits	NULL
.	NULL

Biochim	NULL
.	NULL

Bio-phys	NULL
.	NULL

Acta	NULL
1072:63-80.	NULL
.	NULL

Baeverie	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1988	NULL
.	NULL

Activation	NULL
of	NULL
DNA	NULL
binding	NULL
activity	NULL
in	NULL
an	NULL
apparently	NULL
cytoplasmic	NULL
precursor	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
transcription	NULL
factor	NULL
.	NULL

Cell	NULL
53:211-217.	NULL
.	NULL

Baeuerle	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1988	NULL
.	NULL

IxB	NULL
:	NULL
a	NULL
specific	NULL
inhibitor	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
transcription	NULL
factor	NULL
.	NULL

Science	NULL
242:540-546.	NULL
.	NULL

Baeuerle	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1989	NULL
.	NULL

A	NULL
65-kD	NULL
subunit	NULL
of	NULL
active	NULL
NF-	NULL
«	NULL
B	NULL
is	NULL
required	NULL
for	NULL
inhibition	NULL
of	NULL
NF-B	NULL
by	NULL
IxB	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

3:1689-1698.	NULL
.	NULL

Ballard	NULL
,	NULL
D.	NULL
W.	NULL
,	NULL
E.	NULL
Bohnlein	NULL
,	NULL
J.	NULL
W.	NULL
Lowenthal	NULL
,	NULL
Y.	NULL
Wano	NULL
,	NULL
B.	NULL
R.	NULL
Franza	NULL
,	NULL
and	NULL
W.	NULL
C.	NULL
Greene	NULL
.	NULL

1988	NULL
.	NULL

HTLV-I	NULL
Tax	NULL
induces	NULL
cellular	NULL
proteins	NULL
that	NULL
activates	NULL
the	NULL
kB	NULL
element	NULL
in	NULL
the	NULL
IL-2	NULL
receptor	NULL
a	NULL
gene	NULL
.	NULL

Science	NULL
241:1652-1654.	NULL
.	NULL

Ballard	NULL
,	NULL
D.	NULL
W.	NULL
,	NULL
E.	NULL
P.	NULL
Dixon	NULL
,	NULL
N.	NULL
J.	NULL
Peffer	NULL
,	NULL
H.	NULL
Bogerd	NULL
,	NULL
S.	NULL
Doerre	NULL
,	NULL
B.	NULL
Stein	NULL
,	NULL
and	NULL
W.	NULL
C.	NULL
Greene	NULL
.	NULL

1992	NULL
.	NULL

The	NULL
65-kDa	NULL
subunit	NULL
of	NULL
human	NULL
NF-	NULL
«	NULL
B	NULL
functions	NULL
as	NULL
a	NULL
potent	NULL
transcriptional	NULL
activator	NULL
and	NULL
a	NULL
target	NULL
for	NULL
v-Rel-mediated	NULL
repression	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
89:1875-1879.	NULL
.	NULL

Béraud	NULL
,	NULL
C.	NULL
,	NULL
G.	NULL
Lombard-Platet	NULL
,	NULL
Y.	NULL
Michal	NULL
,	NULL
and	NULL
P.	NULL
Jalinot	NULL
.	NULL

1991	NULL
.	NULL

Binding	NULL
of	NULL
the	NULL
HTLV-I	NULL
Tax1	NULL
transactivator	NULL
to	NULL
the	NULL
inducible	NULL
21	NULL
bp	NULL
enhancer	NULL
is	NULL
mediated	NULL
by	NULL
the	NULL
cellular	NULL
factor	NULL
HEB1	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

10:3795-3803	NULL
.	NULL

Berneman	NULL
,	NULL
Z.	NULL
N.	NULL
,	NULL
R.	NULL
B.	NULL
Gartenhaus	NULL
,	NULL
J.	NULL
Reitz	NULL
M.	NULL
S.	NULL
,	NULL
W.	NULL
A.	NULL
Blattner	NULL
,	NULL
A.	NULL
Manns	NULL
,	NULL
B.	NULL
Hanchard	NULL
,	NULL
O.	NULL
Ikehara	NULL
,	NULL
R.	NULL
C.	NULL
Gailo	NULL
,	NULL
and	NULL
M.	NULL
E.	NULL
Klotman	NULL
.	NULL

1992	NULL
.	NULL

Expression	NULL
of	NULL
alternatively	NULL
spliced	NULL
human	NULL
T-lymphotropic	NULL
virus	NULL
type	NULL
I	NULL
pX	NULL
mRNA	NULL
in	NULL
infected	NULL
cell	NULL
lines	NULL
and	NULL
in	NULL
primary	NULL
uncultured	NULL
cells	NULL
from	NULL
patients	NULL
with	NULL
adult	NULL
T-cell	NULL
leukemia/lymphoma	NULL
and	NULL
healthy	NULL
carrier	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
89:3005-3009	NULL
.	NULL

Blattner	NULL
,	NULL
W.	NULL
A.	NULL
,	NULL
D.	NULL
W.	NULL
Blayney	NULL
,	NULL
M.	NULL
Robert-Guroff	NULL
,	NULL
M.	NULL
G.	NULL
Sarngadbaran	NULL
,	NULL
V.	NULL
S.	NULL
Kalyanaraman	NULL
,	NULL
P.	NULL
S.	NULL
Sarin	NULL
,	NULL
E.	NULL
S.	NULL
Jaffe	NULL
,	NULL
and	NULL
R.	NULL
C.	NULL
Gallo	NULL
.	NULL

1983	NULL
.	NULL

Epidemiology	NULL
of	NULL
human	NULL
T-cell	NULL
leukemia/	NULL
lymphoma	NULL
virus	NULL
.	NULL

J.	NULL
Infect	NULL
.	NULL

Dis	NULL
.	NULL

147:406-416	NULL
.	NULL

Blattner	NULL
,	NULL
W.	NULL
A.	NULL
,	NULL
V.	NULL
S.	NULL
Kallyanaraman	NULL
,	NULL
M.	NULL
Robert-Guroff	NULL
,	NULL
T.	NULL
A.	NULL
Lister	NULL
,	NULL
D.	NULL
A.	NULL
G.	NULL
Galton	NULL
,	NULL
P.	NULL
S.	NULL
Sarin	NULL
,	NULL
M.	NULL
H.	NULL
Crawford	NULL
,	NULL
D.	NULL
Catovsky	NULL
,	NULL
M.	NULL
Greaves	NULL
,	NULL
and	NULL
R.	NULL
C.	NULL
Gallo	NULL
.	NULL

1982	NULL
.	NULL

The	NULL
human	NULL
type	NULL
C	NULL
retrovirus	NULL
,	NULL
HTLV	NULL
,	NULL
in	NULL
blacks	NULL
from	NULL
the	NULL
Caribbean	NULL
region	NULL
,	NULL
and	NULL
relationship	NULL
to	NULL
adult	NULL
T-cell	NULL
leukemia/lymphoma	NULL
.	NULL

Int	NULL
.	NULL

J	NULL
.	NULL

Cancer	NULL
30:257-264	NULL
.	NULL

Bohnlein	NULL
,	NULL
E.	NULL
,	NULL
M.	NULL
Sickevitz	NULL
,	NULL
D.	NULL
W.	NULL
Ballard	NULL
,	NULL
J.	NULL
W.	NULL
Lowenthal	NULL
,	NULL
L.	NULL
Rimsky	NULL
,	NULL
H.	NULL
Bogerd	NULL
,	NULL
J.	NULL
Hoffman	NULL
,	NULL
Y.	NULL
Wano	NULL
,	NULL
B.	NULL
R.	NULL
Franza	NULL
,	NULL
and	NULL
W.	NULL
C.	NULL
Greene	NULL
.	NULL

1989	NULL
.	NULL

Stimulation	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
I	NULL
enhancer	NULL
by	NULL
the	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
I	NULL
tax	NULL
gene	NULL
product	NULL
involves	NULL
the	NULL
activation	NULL
of	NULL
inducible	NULL
cellular	NULL
proteins	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

63:1578-1586	NULL
.	NULL

Bours	NULL
,	NULL
V.	NULL
,	NULL
J.	NULL
Villalobos	NULL
,	NULL
P.	NULL
R.	NULL
Burd	NULL
,	NULL
K.	NULL
Kelly	NULL
,	NULL
and	NULL
U.	NULL
Siebenlist	NULL
.	NULL

1990	NULL
.	NULL

Cloning	NULL
of	NULL
a	NULL
mitogen-inducible	NULL
gene	NULL
encoding	NULL
a	NULL
kB	NULL
DNA-binding	NULL
protein	NULL
with	NULL
homology	NULL
to	NULL
the	NULL
re/	NULL
oncogene	NULL
and	NULL
to	NULL
cell-cycle	NULL
motifs	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
348:76-80	NULL
.	NULL

Bours	NULL
,	NULL
V.	NULL
,	NULL
J.	NULL
Villalobos	NULL
,	NULL
P.	NULL
R.	NULL
Burd	NULL
,	NULL
K.	NULL
Kelly	NULL
,	NULL
and	NULL
U.	NULL
Siebenlist	NULL
.	NULL

1992	NULL
.	NULL

A	NULL
novel	NULL
mitogen-inducible	NULL
gene	NULL
product	NULL
related	NULL
to	NULL
p50-p1l05-NF-	NULL
«	NULL
B	NULL
participates	NULL
in	NULL
transactivation	NULL
through	NULL
a	NULL
«	NULL
B	NULL
site	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

12:685-695	NULL
.	NULL

Brownell	NULL
,	NULL
E.	NULL
,	NULL
N.	NULL
Mittereder	NULL
,	NULL
and	NULL
N.	NULL
Rice	NULL
.	NULL

1989	NULL
.	NULL

A	NULL
human	NULL
re/	NULL
proto-oncogene	NULL
cDNA	NULL
containing	NULL
an	NULL
Alu	NULL
fragment	NULL
as	NULL
a	NULL
potential	NULL
coding	NULL
exon	NULL
.	NULL

Oncogene	NULL
4:935-942	NULL
.	NULL

Catovsky	NULL
,	NULL
D.	NULL
,	NULL
M.	NULL
Rose	NULL
,	NULL
A.	NULL
W.	NULL
G.	NULL
Goolden	NULL
,	NULL
J.	NULL
M.	NULL
White	NULL
,	NULL
G.	NULL
Bourikas	NULL
,	NULL
A.	NULL
I.	NULL
Brownell	NULL
,	NULL
W.	NULL
A.	NULL
Blattner	NULL
,	NULL
M.	NULL
F.	NULL
Greaves	NULL
,	NULL
D.	NULL
A.	NULL
G.	NULL
Galton	NULL
,	NULL
D.	NULL
R.	NULL
McCluskey	NULL
,	NULL
I.	NULL
Lampert	NULL
,	NULL
R.	NULL
Ireland	NULL
,	NULL
J.	NULL
M.	NULL
Bridges	NULL
,	NULL
and	NULL
R.	NULL
C.	NULL
Gallo	NULL
.	NULL

1982	NULL
.	NULL

Adult	NULL
T-cell	NULL
leukemia/lymphoma	NULL
in	NULL
blacks	NULL
from	NULL
the	NULL
West	NULL
Indies	NULL
.	NULL

Lancet	NULL
i:639-643	NULL
.	NULL

Cesarman	NULL
,	NULL
E.	NULL
,	NULL
A.	NULL
Chadburn	NULL
,	NULL
G.	NULL
Inghirami	NULL
,	NULL
G.	NULL
Gaidano	NULL
,	NULL
and	NULL
D.	NULL
M.	NULL
Knowles	NULL
.	NULL

1992	NULL
.	NULL

Structural	NULL
and	NULL
functional	NULL
analysis	NULL
of	NULL
oncogenes	NULL
and	NULL
tumor	NULL
suppressor	NULL
genes	NULL
in	NULL
adult	NULL
T-cell	NULL
leukemia/	NULL
lymphoma	NULL
shows	NULL
frequent	NULL
p53	NULL
mutations	NULL
.	NULL

Blood	NULL
80:3205-3216	NULL
.	NULL

Chen	NULL
,	NULL
I.	NULL
S.	NULL
Y.	NULL
,	NULL
D.	NULL
J.	NULL
Slamon	NULL
,	NULL
J.	NULL
D.	NULL
Rosenblatt	NULL
,	NULL
N.	NULL
P.	NULL
Shah	NULL
,	NULL
S.	NULL
G.	NULL
Quan	NULL
,	NULL
and	NULL
W.	NULL
Wachsman	NULL
.	NULL

1985	NULL
.	NULL

The	NULL
x	NULL
gene	NULL
is	NULL
essential	NULL
of	NULL
HTLV	NULL
replication	NULL
.	NULL

Science	NULL
229:54-58	NULL
.	NULL

Crenon	NULL
,	NULL
I.	NULL
,	NULL
C.	NULL
Béraud	NULL
,	NULL
P.	NULL
Simard	NULL
,	NULL
J.	NULL
Montagne	NULL
,	NULL
P.	NULL
Veschambre	NULL
,	NULL
Vor	NULL
.	NULL

14	NULL
,	NULL
1994	NULL
21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37.	NULL
and	NULL
P.	NULL
Jalinot	NULL
.	NULL

1993	NULL
.	NULL

The	NULL
transcriptionally	NULL
active	NULL
factors	NULL
mediating	NULL
the	NULL
effect	NULL
of	NULL
the	NULL
HTLV-I	NULL
Tax	NULL
transactivator	NULL
on	NULL
the	NULL
IL2-Ra	NULL
«	NULL
B	NULL
enhancer	NULL
include	NULL
the	NULL
product	NULL
of	NULL
the	NULL
c-rel	NULL
proto-oncogene	NULL
.	NULL

Oncogene	NULL
8:867-875	NULL
.	NULL

Cross	NULL
,	NULL
S.	NULL
L.	NULL
,	NULL
M.	NULL
B.	NULL
Feinberg	NULL
,	NULL
J	NULL
.	NULL

B.	NULL
Wolf	NULL
,	NULL
N.	NULL
J.	NULL
Holbrook	NULL
,	NULL
F.	NULL
Wong-Staal	NULL
,	NULL
and	NULL
W.	NULL
J.	NULL
Leonard	NULL
.	NULL

1987	NULL
.	NULL

Regulation	NULL
of	NULL
the	NULL
human	NULL
interleukin-2	NULL
receptor	NULL
a	NULL
chain	NULL
promoter	NULL
:	NULL
activation	NULL
of	NULL
a	NULL
non	NULL
functional	NULL
promoter	NULL
by	NULL
the	NULL
transactivator	NULL
gene	NULL
of	NULL
HTLV-I	NULL
.	NULL

Cell	NULL
49:47-56	NULL
.	NULL

Fan	NULL
,	NULL
C.	NULL
M.	NULL
,	NULL
and	NULL
T.	NULL
Maniatis	NULL
.	NULL

1991	NULL
.	NULL

Generation	NULL
of	NULL
p50	NULL
subunit	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
by	NULL
processing	NULL
of	NULL
p105	NULL
through	NULL
an	NULL
ATP-dependent	NULL
pathway	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
354	NULL
;	NULL
:395-398	NULL
.	NULL

Fleming	NULL
,	NULL
A.	NULL
F.	NULL
,	NULL
R.	NULL
Mabarajan	NULL
,	NULL
M.	NULL
Abraham	NULL
,	NULL
A.	NULL
G.	NULL
Kulkarni	NULL
,	NULL
S.	NULL
R.	NULL
Bhusnurmath	NULL
,	NULL
R.	NULL
A.	NULL
Okpara	NULL
,	NULL
E.	NULL
Williams	NULL
,	NULL
I.	NULL
Akinsete	NULL
,	NULL
J.	NULL
Schneider	NULL
,	NULL
H.	NULL
Bayer	NULL
,	NULL
and	NULL
G.	NULL
Hunsmann	NULL
.	NULL

1986	NULL
.	NULL

Antibodies	NULL
to	NULL
HTLV-I	NULL
in	NULL
Nigerian	NULL
blood-donors	NULL
,	NULL
their	NULL
relatives	NULL
and	NULL
patients	NULL
with	NULL
leukaemias	NULL
,	NULL
lymphomas	NULL
and	NULL
other	NULL
diseases	NULL
.	NULL

Int	NULL
.	NULL

J	NULL
.	NULL

Cancer	NULL
38:809-813	NULL
.	NULL

Franzoso	NULL
,	NULL
G.	NULL
,	NULL
V.	NULL
Bours	NULL
,	NULL
S.	NULL
Park	NULL
,	NULL
M.	NULL
Tomita-Yamaguchi	NULL
,	NULL
K.	NULL
Kelly	NULL
,	NULL
and	NULL
U.	NULL
Siebenlist	NULL
.	NULL

1992	NULL
.	NULL

The	NULL
candidate	NULL
oncoprotein	NULL
Bcl-3	NULL
is	NULL
an	NULL
antagonist	NULL
of	NULL
pS50/NF-	NULL
«	NULL
B-mediated	NULL
inhibition	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
359:339-342.	NULL
.	NULL

Fujii	NULL
,	NULL
M.	NULL
,	NULL
P.	NULL
Sassone-Corsi	NULL
,	NULL
and	NULL
I.	NULL
M.	NULL
Verma	NULL
.	NULL

1988.	NULL
c-fos	NULL
promoter	NULL
transactivation	NULL
by	NULL
the	NULL
tax	NULL
,	NULL
protein	NULL
of	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
I.	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
85:8526-8530	NULL
.	NULL

Fujii	NULL
,	NULL
M.	NULL
,	NULL
H.	NULL
Tsuchiya	NULL
,	NULL
T.	NULL
Chubjo	NULL
,	NULL
T.	NULL
Akizawa	NULL
,	NULL
and	NULL
M.	NULL
Seiki	NULL
.	NULL

1992	NULL
.	NULL

Interaction	NULL
of	NULL
HTLV-I	NULL
Taxl	NULL
with	NULL
p67°	NULL
``	NULL
~	NULL
``	NULL
causes	NULL
the	NULL
aberrant	NULL
induction	NULL
of	NULL
cellular	NULL
immediate	NULL
early	NULL
genes	NULL
through	NULL
CArG	NULL
boxes	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

6:2066-2076	NULL
.	NULL

Gallo	NULL
,	NULL
R.	NULL
C.	NULL
,	NULL
V.	NULL
S.	NULL
Kalyanaraman	NULL
,	NULL
M.	NULL
G.	NULL
Sarngadharan	NULL
,	NULL
A.	NULL
Sliski	NULL
,	NULL
E.	NULL
C.	NULL
Vonderheid	NULL
,	NULL
M.	NULL
Maeda	NULL
,	NULL
Y.	NULL
Nakao	NULL
,	NULL
K.	NULL
Yamada	NULL
,	NULL
Y.	NULL
Ito	NULL
,	NULL
N.	NULL
Gutensohn	NULL
,	NULL
S.	NULL
Murphy	NULL
,	NULL
P.	NULL
A.	NULL
Bunn	NULL
,	NULL
D.	NULL
Catovsky	NULL
,	NULL
M.	NULL
F.	NULL
Greaves	NULL
,	NULL
D.	NULL
W.	NULL
Blayney	NULL
,	NULL
W.	NULL
Blattner	NULL
,	NULL
W.	NULL
F.	NULL
H.	NULL
Jarrett	NULL
,	NULL
H.	NULL
zur	NULL
Hausen	NULL
,	NULL
M.	NULL
Seligmann	NULL
,	NULL
J.	NULL
C.	NULL
Brouet	NULL
,	NULL
B.	NULL
F.	NULL
Haynes	NULL
,	NULL
B.	NULL
V.	NULL
Jegasothy	NULL
,	NULL
E.	NULL
Jaffe	NULL
,	NULL
J.	NULL
Cossman	NULL
,	NULL
S.	NULL
Broder	NULL
,	NULL
R.	NULL
I.	NULL
Fisher	NULL
,	NULL
D.	NULL
W.	NULL
Golde	NULL
,	NULL
and	NULL
M.	NULL
Robert-Guroff	NULL
.	NULL

1983	NULL
.	NULL

Association	NULL
of	NULL
the	NULL
human	NULL
type	NULL
C	NULL
retrovirus	NULL
with	NULL
a	NULL
subset	NULL
of	NULL
adult	NULL
T-cell	NULL
cancers	NULL
.	NULL

Cancer	NULL
Res	NULL
.	NULL

43:3892-3899.	NULL
.	NULL

Ganchi	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
S.-C.	NULL
Sun	NULL
,	NULL
D.	NULL
W.	NULL
Ballard	NULL
,	NULL
and	NULL
W.	NULL
C.	NULL
Greene	NULL
.	NULL

1992	NULL
.	NULL

IxB/MAD-3	NULL
masks	NULL
the	NULL
nuclear	NULL
localization	NULL
signal	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
and	NULL
acts	NULL
with	NULL
the	NULL
C-terminal	NULL
activation	NULL
domain	NULL
to	NULL
inhibit	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
DNA	NULL
binding	NULL
.	NULL

Mol	NULL
.	NULL

Biol	NULL
.	NULL

Cell	NULL
3:1339-1352	NULL
.	NULL

Geisler	NULL
,	NULL
R.	NULL
,	NULL
A.	NULL
Bergmann	NULL
,	NULL
Y.	NULL
Hiromi	NULL
,	NULL
and	NULL
C.	NULL
Nusslein-Volhard	NULL
.	NULL

1992.	NULL
cactus	NULL
,	NULL
a	NULL
gene	NULL
involved	NULL
in	NULL
dorsoventral	NULL
pattern	NULL
formation	NULL
of	NULL
Drosophila	NULL
,	NULL
is	NULL
related	NULL
to	NULL
the	NULL
IxB	NULL
gene	NULL
family	NULL
of	NULL
vertebrates	NULL
.	NULL

Cell	NULL
71:613-621	NULL
.	NULL

Gessain	NULL
,	NULL
A.	NULL
,	NULL
F.	NULL
Barin	NULL
,	NULL
J.	NULL
C.	NULL
Vernant	NULL
,	NULL
O.	NULL
Gout	NULL
,	NULL
L.	NULL
Maurs	NULL
,	NULL
A.	NULL
Calender	NULL
,	NULL
and	NULL
G.	NULL
de	NULL
The	NULL
.	NULL

1985	NULL
.	NULL

Antibodies	NULL
to	NULL
the	NULL
human	NULL
T-lymphotropic	NULL
virus	NULL
type-l	NULL
in	NULL
patients	NULL
with	NULL
tropical	NULL
spastic	NULL
paraparesis	NULL
.	NULL

Lancet	NULL
ii:407-410	NULL
.	NULL

Ghosh	NULL
,	NULL
S.	NULL
,	NULL
A.	NULL
M.	NULL
Gifford	NULL
,	NULL
L.	NULL
R.	NULL
Riviere	NULL
,	NULL
P.	NULL
Tempst	NULL
,	NULL
G.	NULL
P.	NULL
Nolan	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1990	NULL
.	NULL

Cloning	NULL
of	NULL
the	NULL
p50	NULL
DNA	NULL
binding	NULL
subunit	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
:	NULL
homology	NULL
to	NULL
rel	NULL
and	NULL
dorsal	NULL
.	NULL

Cell	NULL
62:1019-1029	NULL
.	NULL

Gibbs	NULL
,	NULL
W.	NULL
N.	NULL
,	NULL
W.	NULL
S.	NULL
Lofters	NULL
,	NULL
N.	NULL
Campbell	NULL
,	NULL
B.	NULL
Hanchard	NULL
,	NULL
L.	NULL
La	NULL
Grenade	NULL
,	NULL
B.	NULL
Cranston	NULL
,	NULL
J.	NULL
Hendriks	NULL
,	NULL
E.	NULL
S.	NULL
Jaffe	NULL
,	NULL
C.	NULL
Saxinger	NULL
,	NULL
M.	NULL
Robert-Guroff	NULL
,	NULL
R.	NULL
C.	NULL
Gallo	NULL
,	NULL
J.	NULL
Clark	NULL
,	NULL
and	NULL
W.	NULL
A.	NULL
Blattner	NULL
.	NULL

1987	NULL
.	NULL

Non-Hodgkin	NULL
lymphoma	NULL
in	NULL
Jamaica	NULL
and	NULL
its	NULL
relation	NULL
to	NULL
adult	NULL
T-cell	NULL
leukemia/lymphoma	NULL
.	NULL

Ann	NULL
.	NULL

Intern	NULL
.	NULL

Med	NULL
.	NULL

106:361-368	NULL
.	NULL

Gilmore	NULL
,	NULL
T.	NULL
D.	NULL
1990	NULL
.	NULL

NF-	NULL
«	NULL
B	NULL
,	NULL
KBF1	NULL
,	NULL
dorsal	NULL
,	NULL
and	NULL
related	NULL
mat-ters	NULL
.	NULL

Cell	NULL
62:841-843	NULL
.	NULL

Gilmore	NULL
,	NULL
T.	NULL
D.	NULL
1991	NULL
.	NULL

Malignant	NULL
transformation	NULL
by	NULL
mutant	NULL
rel	NULL
proteins	NULL
.	NULL

Trends	NULL
Genet	NULL
.	NULL

7:318-322	NULL
.	NULL

Green	NULL
,	NULL
P.	NULL
L.	NULL
,	NULL
and	NULL
I.	NULL
S.	NULL
Y.	NULL
Chen	NULL
.	NULL

1990	NULL
.	NULL

Regulation	NULL
of	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
expression	NULL
.	NULL

FASEB	NULL
J	NULL
.	NULL

4:169-175	NULL
.	NULL

Haskill	NULL
,	NULL
S.	NULL
,	NULL
A	NULL
.	NULL

A.	NULL
Beg	NULL
,	NULL
S.	NULL
M.	NULL
Tompkins	NULL
,	NULL
J.	NULL
S.	NULL
Morris	NULL
,	NULL
A.	NULL
D.	NULL
Yurochko	NULL
,	NULL
A.	NULL
Sampson-Johannes	NULL
,	NULL
K.	NULL
Mondal	NULL
,	NULL
P.	NULL
Ralph	NULL
,	NULL
and	NULL
A.	NULL
S.	NULL
Baldwin	NULL
Jr.	NULL
1991	NULL
.	NULL

Characterization	NULL
of	NULL
an	NULL
immediate-early	NULL
gene	NULL
induced	NULL
in	NULL
adherent	NULL
monocytes	NULL
that	NULL
encodes	NULL
IxB-like	NULL
activity	NULL
.	NULL

Cell	NULL
65:1281-1289	NULL
.	NULL

Hatada	NULL
,	NULL
E.	NULL
N.	NULL
,	NULL
A.	NULL
Nieters	NULL
,	NULL
F.	NULL
G.	NULL
Wulczyn	NULL
,	NULL
M.	NULL
Naumann	NULL
,	NULL
R.	NULL
Meyer	NULL
,	NULL
G.	NULL
Nucifora	NULL
,	NULL
T.	NULL
W.	NULL
McKeithan	NULL
,	NULL
and	NULL
C.	NULL
Scheidereit	NULL
.	NULL

1992	NULL
.	NULL

The	NULL
ankyrin	NULL
repeat	NULL
domains	NULL
of	NULL
the	NULL
NF-kappa	NULL
B	NULL
precursor	NULL
p105	NULL
38	NULL
.	NULL

39	NULL
.	NULL

41	NULL
.	NULL

42	NULL
.	NULL

43	NULL
.	NULL

45	NULL
.	NULL

47	NULL
.	NULL

49	NULL
.	NULL

50	NULL
.	NULL

51	NULL
.	NULL

52	NULL
.	NULL

53	NULL
.	NULL

54	NULL
.	NULL

55	NULL
.	NULL

HTLV-I	NULL
Tax	NULL
IS	NULL
REGULATED	NULL
BY	NULL
NF-kB	NULL
p100	NULL
1381	NULL
and	NULL
the	NULL
protooncogene	NULL
be/-3	NULL
act	NULL
as	NULL
specific	NULL
inhibitors	NULL
of	NULL
NF-kappa	NULL
B	NULL
DNA	NULL
binding	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
89:2489-2493	NULL
.	NULL

Hinrichs	NULL
,	NULL
S.	NULL
H.	NULL
,	NULL
M.	NULL
Nerenberg	NULL
,	NULL
K.	NULL
Reynolds	NULL
,	NULL
G.	NULL
Khoury	NULL
,	NULL
and	NULL
G.	NULL
Jay	NULL
.	NULL

1987	NULL
.	NULL

A	NULL
transgenic	NULL
mouse	NULL
model	NULL
for	NULL
human	NULL
neurofibroma-tosis	NULL
.	NULL

Science	NULL
237:1340-1343	NULL
.	NULL

Hinuma	NULL
,	NULL
Y.	NULL
,	NULL
H.	NULL
Komoda	NULL
,	NULL
T.	NULL
Chosa	NULL
,	NULL
T.	NULL
Kondo	NULL
,	NULL
M.	NULL
Kohakura	NULL
,	NULL
T.	NULL
Takenaka	NULL
,	NULL
M.	NULL
Kikuchi	NULL
,	NULL
M.	NULL
Ichimaru	NULL
,	NULL
K.	NULL
Yunoki	NULL
,	NULL
I.	NULL
Sato	NULL
,	NULL
R.	NULL
Matsuo	NULL
,	NULL
Y.	NULL
Takiuchi	NULL
,	NULL
H.	NULL
Uchino	NULL
,	NULL
and	NULL
M.	NULL
Hanaoka	NULL
.	NULL

1982	NULL
.	NULL

Antibodies	NULL
to	NULL
adult	NULL
T-cell	NULL
leukemia-virus-associated	NULL
antigen	NULL
(	NULL
ATLA	NULL
)	NULL
in	NULL
sera	NULL
from	NULL
patients	NULL
with	NULL
ATL	NULL
and	NULL
controls	NULL
in	NULL
Japan	NULL
:	NULL
a	NULL
nation-wide	NULL
sero-epidemiologic	NULL
study	NULL
.	NULL

Int	NULL
.	NULL

J	NULL
.	NULL

Cancer	NULL
29:631-635.	NULL
.	NULL

Hirai	NULL
,	NULL
H.	NULL
,	NULL
J.	NULL
Fujisawa	NULL
,	NULL
T.	NULL
Suzuki	NULL
,	NULL
K.	NULL
Ueda	NULL
,	NULL
M.	NULL
Muramatsu	NULL
,	NULL
A.	NULL
Tsuboi	NULL
,	NULL
N.	NULL
Arai	NULL
,	NULL
and	NULL
M.	NULL
Yoshida	NULL
.	NULL

1992	NULL
.	NULL

Transcriptional	NULL
activator	NULL
Tax	NULL
of	NULL
HTLV-I	NULL
binds	NULL
to	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
precursor	NULL
p105	NULL
.	NULL

Oncogene	NULL
7:1737-1742	NULL
.	NULL

Holbrook	NULL
,	NULL
N.	NULL
,	NULL
A.	NULL
Gulino	NULL
,	NULL
and	NULL
F.	NULL
Ruscetti	NULL
.	NULL

1987	NULL
.	NULL

Cis-acting	NULL
transcriptional	NULL
regulatory	NULL
sequences	NULL
in	NULL
the	NULL
gibbon	NULL
ape	NULL
leukemia	NULL
virus	NULL
(	NULL
GALV	NULL
)	NULL
long	NULL
terminal	NULL
repeat	NULL
.	NULL

Virology	NULL
157:211-219	NULL
.	NULL

Inoue	NULL
,	NULL
J.	NULL
,	NULL
M.	NULL
Seiki	NULL
,	NULL
T.	NULL
Taniguchi	NULL
,	NULL
S.	NULL
Tsuru	NULL
,	NULL
and	NULL
M.	NULL
Yoshida	NULL
.	NULL

1986	NULL
.	NULL

Induction	NULL
of	NULL
interleukine-2	NULL
receptor	NULL
gene	NULL
expression	NULL
by	NULL
p40	NULL
``	NULL
encoded	NULL
by	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
I.	NULL
EMBO	NULL
J	NULL
.	NULL

5:2883-2888	NULL
.	NULL

Inoue	NULL
,	NULL
J.	NULL
I.	NULL
,	NULL
L.	NULL
D.	NULL
Kerr	NULL
,	NULL
A.	NULL
Kakizuka	NULL
,	NULL
and	NULL
I.	NULL
M.	NULL
Verma	NULL
.	NULL

1992	NULL
.	NULL

IxBy	NULL
,	NULL
a	NULL
70	NULL
kd	NULL
protein	NULL
identical	NULL
to	NULL
the	NULL
C-terminal	NULL
half	NULL
of	NULL
p110	NULL
NF-	NULL
«	NULL
B	NULL
:	NULL
a	NULL
new	NULL
member	NULL
of	NULL
the	NULL
IxB	NULL
family	NULL
.	NULL

Cell	NULL
68:1109-1120.	NULL
.	NULL

Jaffe	NULL
,	NULL
E.	NULL
S.	NULL
,	NULL
W.	NULL
A.	NULL
Blattner	NULL
,	NULL
D.	NULL
W.	NULL
Blayney	NULL
,	NULL
P.	NULL
A.	NULL
Bunn	NULL
,	NULL
J.	NULL
Cossman	NULL
,	NULL
M.	NULL
Robert-Guroff	NULL
,	NULL
and	NULL
R.	NULL
C.	NULL
Gallo	NULL
.	NULL

1984	NULL
.	NULL

The	NULL
patho-logic	NULL
spectrum	NULL
of	NULL
adult	NULL
T-cell	NULL
leukemia/lymphoma	NULL
in	NULL
the	NULL
United	NULL
States	NULL
.	NULL

Am	NULL
.	NULL

J.	NULL
Surg	NULL
.	NULL

Pathol	NULL
.	NULL

8:263-275	NULL
.	NULL

Kidd	NULL
,	NULL
S.	NULL
1992	NULL
.	NULL

Characterization	NULL
of	NULL
the	NULL
Drosophila	NULL
cactus	NULL
locus	NULL
and	NULL
analysis	NULL
of	NULL
interactions	NULL
between	NULL
cactus	NULL
and	NULL
dorsal	NULL
proteins	NULL
.	NULL

Cell	NULL
71:623-635.	NULL
.	NULL

Kieran	NULL
,	NULL
M.	NULL
,	NULL
V.	NULL
Blank	NULL
,	NULL
F.	NULL
Logeat	NULL
,	NULL
J.	NULL
Vandekerckhove	NULL
,	NULL
F.	NULL
Lott	NULL
speich	NULL
,	NULL
O	NULL
.	NULL

Le	NULL
Bail	NULL
,	NULL
M.	NULL
B	NULL
.	NULL

Urban	NULL
,	NULL
P.	NULL
Kourilsky	NULL
,	NULL
P.	NULL
A.	NULL
Baeuerle	NULL
,	NULL
and	NULL
A.	NULL
Israel	NULL
.	NULL

1990	NULL
.	NULL

The	NULL
DNA	NULL
binding	NULL
subunit	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
is	NULL
identical	NULL
to	NULL
factor	NULL
KBF-1	NULL
and	NULL
homologous	NULL
to	NULL
the	NULL
ref	NULL
oncogene	NULL
product	NULL
.	NULL

Cell	NULL
62:1007-1018	NULL
.	NULL

Kim	NULL
,	NULL
J.	NULL
H.	NULL
,	NULL
and	NULL
D.	NULL
T.	NULL
Durack	NULL
.	NULL

1988	NULL
.	NULL

Manifestations	NULL
of	NULL
human	NULL
T-lymphotropic	NULL
virus	NULL
type	NULL
I	NULL
infection	NULL
.	NULL

Am	NULL
.	NULL

J.	NULL
Med	NULL
.	NULL

84:919-928.	NULL
.	NULL

Levine	NULL
,	NULL
P.	NULL
H.	NULL
,	NULL
W.	NULL
A.	NULL
Blattner	NULL
,	NULL
J.	NULL
Clark	NULL
,	NULL
R.	NULL
Tarone	NULL
,	NULL
E.	NULL
M.	NULL
Maloney	NULL
,	NULL
E.	NULL
M.	NULL
Murphy	NULL
,	NULL
R.	NULL
C.	NULL
Gallo	NULL
,	NULL
M.	NULL
Robert-Guroff	NULL
,	NULL
and	NULL
W.	NULL
C.	NULL
Saxinger	NULL
.	NULL

1988	NULL
.	NULL

Geographic	NULL
distribution	NULL
of	NULL
HTLV-I	NULL
and	NULL
identification	NULL
of	NULL
a	NULL
new	NULL
high-risk	NULL
population	NULL
.	NULL

Int	NULL
.	NULL

J	NULL
.	NULL

Cancer	NULL
42:7-12	NULL
.	NULL

Liou	NULL
,	NULL
H.-C.	NULL
,	NULL
P.	NULL
N.	NULL
Garry	NULL
,	NULL
S.	NULL
Ghosh	NULL
,	NULL
T.	NULL
Fujita	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1992	NULL
.	NULL

The	NULL
NF-kB	NULL
p50	NULL
precursor	NULL
,	NULL
p105	NULL
,	NULL
contains	NULL
an	NULL
internal	NULL
IxB-like	NULL
inhibitor	NULL
that	NULL
preferentially	NULL
inhibits	NULL
p50	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

11:3003-3009	NULL
.	NULL

Maruyama	NULL
,	NULL
M.	NULL
,	NULL
H.	NULL
Shibuya	NULL
,	NULL
H.	NULL
Harada	NULL
,	NULL
M.	NULL
Hatakeyama	NULL
,	NULL
M.	NULL
Seiki	NULL
,	NULL
T.	NULL
Fujita	NULL
,	NULL
J.	NULL
I.	NULL
Inoue	NULL
,	NULL
M.	NULL
Yoshida	NULL
,	NULL
and	NULL
T.	NULL
Taniguchi	NULL
.	NULL

1987	NULL
.	NULL

Evidence	NULL
for	NULL
aberrant	NULL
activation	NULL
of	NULL
the	NULL
interleukin-2	NULL
autocrine	NULL
loop	NULL
by	NULL
HTLV-l-encoded	NULL
p40x	NULL
and	NULL
T3/Ti	NULL
complex	NULL
triggering	NULL
.	NULL

Cell	NULL
48:343-350	NULL
.	NULL

Mercurio	NULL
,	NULL
F.	NULL
,	NULL
J.	NULL
DiDonato	NULL
,	NULL
C.	NULL
Rosette	NULL
,	NULL
and	NULL
M.	NULL
Karin	NULL
.	NULL

1992	NULL
.	NULL

Molecular	NULL
cloning	NULL
and	NULL
characterization	NULL
of	NULL
a	NULL
novel	NULL
Rel/NF-	NULL
«	NULL
B	NULL
family	NULL
member	NULL
displaying	NULL
structural	NULL
and	NULL
functional	NULL
homology	NULL
to	NULL
NF-	NULL
«	NULL
B	NULL
p50/p105	NULL
.	NULL

DNA	NULL
Cell	NULL
.	NULL

Biol	NULL
.	NULL

11:523-537	NULL
.	NULL

Mercurio	NULL
,	NULL
F.	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
DiDonato	NULL
,	NULL
C.	NULL
Rosette	NULL
,	NULL
and	NULL
M.	NULL
Karin	NULL
.	NULL

1993.	NULL
p105	NULL
and	NULL
p98	NULL
precursor	NULL
proteins	NULL
play	NULL
an	NULL
active	NULL
role	NULL
in	NULL
NF-	NULL
«	NULL
B-mediated	NULL
signal	NULL
transduction	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

7:705-718	NULL
.	NULL

Meyer	NULL
,	NULL
R.	NULL
,	NULL
E.	NULL
N.	NULL
Hatada	NULL
,	NULL
H.-P.	NULL
Hohmann	NULL
,	NULL
M.	NULL
Haiker	NULL
,	NULL
C.	NULL
Bartsch	NULL
,	NULL
U.	NULL
Rothlisberger	NULL
,	NULL
H.-W.	NULL
Lahm	NULL
,	NULL
E.	NULL
J.	NULL
Schlaeger	NULL
,	NULL
A.	NULL
P.	NULL
G.	NULL
M.	NULL
van	NULL
Loon	NULL
,	NULL
and	NULL
C.	NULL
Schreidereit	NULL
.	NULL

1991	NULL
.	NULL

Cloning	NULL
of	NULL
the	NULL
DNA-binding	NULL
subunit	NULL
of	NULL
human	NULL
nuclear	NULL
factor	NULL
«	NULL
B	NULL
:	NULL
the	NULL
level	NULL
of	NULL
its	NULL
mRNA	NULL
is	NULL
strongly	NULL
regulated	NULL
by	NULL
phorbol	NULL
ester	NULL
or	NULL
tumor	NULL
necrosis	NULL
factor	NULL
a.	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
88:966-970	NULL
.	NULL

Nagata	NULL
,	NULL
K.	NULL
,	NULL
K.	NULL
Ohtani	NULL
,	NULL
M.	NULL
Nakamura	NULL
,	NULL
and	NULL
K.	NULL
Sugamura	NULL
.	NULL

1989	NULL
.	NULL

Activation	NULL
of	NULL
endogenous	NULL
c-fos	NULL
proto-oncogene	NULL
by	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
I-encoded	NULL
protein	NULL
in	NULL
the	NULL
human	NULL
T-cell	NULL
line	NULL
,	NULL
Jurkat	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

63:3220-3226	NULL
.	NULL

Naumann	NULL
,	NULL
M.	NULL
,	NULL
F.	NULL
G.	NULL
Wulezyn	NULL
,	NULL
and	NULL
C.	NULL
Scheidereit	NULL
.	NULL

1993	NULL
.	NULL

The	NULL
1382	NULL
56	NULL
.	NULL

57	NULL
.	NULL

58	NULL
.	NULL

59	NULL
.	NULL

61	NULL
.	NULL

62	NULL
.	NULL

63	NULL
.	NULL

65	NULL
.	NULL

66	NULL
.	NULL

67	NULL
.	NULL

68	NULL
.	NULL

69	NULL
.	NULL

70	NULL
.	NULL

71	NULL
.	NULL

72	NULL
.	NULL

73	NULL
.	NULL

BERAUD	NULL
ET	NULL
AL	NULL
.	NULL

NF-kB	NULL
precursor	NULL
p105	NULL
and	NULL
the	NULL
proto-oncogene	NULL
product	NULL
Bcl-l	NULL
are	NULL
IxB	NULL
molecules	NULL
and	NULL
control	NULL
nuclear	NULL
translocation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

12:213-222	NULL
.	NULL

Nerenberg	NULL
,	NULL
M.	NULL
,	NULL
S.	NULL
H.	NULL
Hinrichs	NULL
,	NULL
R.	NULL
K.	NULL
Reynolds	NULL
,	NULL
G.	NULL
Khoury	NULL
,	NULL
and	NULL
G.	NULL
Jay	NULL
.	NULL

1987	NULL
.	NULL

The	NULL
tat	NULL
gene	NULL
of	NULL
human	NULL
T-lymphotropic	NULL
virus	NULL
type	NULL
I	NULL
induces	NULL
mesenchymal	NULL
tumors	NULL
in	NULL
transgenic	NULL
mice	NULL
.	NULL

Science	NULL
237:1324-1329	NULL
.	NULL

Neri	NULL
,	NULL
A.	NULL
,	NULL
C.-C.	NULL
Chang	NULL
,	NULL
L.	NULL
Lombardi	NULL
,	NULL
M.	NULL
Salina	NULL
,	NULL
P.	NULL
Corradini	NULL
,	NULL
A.	NULL
T.	NULL
Maiolo	NULL
,	NULL
R.	NULL
S.	NULL
K.	NULL
Chaganti	NULL
,	NULL
and	NULL
R.	NULL
Dalla-Favera	NULL
.	NULL

1991	NULL
.	NULL

B	NULL
cell	NULL
Iymphoma-associated	NULL
chromosomal	NULL
translocation	NULL
involves	NULL
candidate	NULL
oncogene	NULL
lys-10	NULL
,	NULL
homologous	NULL
to	NULL
NF-kB	NULL
p50	NULL
.	NULL

Cell	NULL
67:1075-1087	NULL
.	NULL

Nolan	NULL
,	NULL
G.	NULL
P.	NULL
,	NULL
S.	NULL
Ghosh	NULL
,	NULL
H.-C.	NULL
Liou	NULL
,	NULL
P.	NULL
Tempst	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1991	NULL
.	NULL

DNA	NULL
binding	NULL
and	NULL
IxB	NULL
inhibition	NULL
of	NULL
the	NULL
cloned	NULL
p65	NULL
subunit	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
a	NULL
rel-related	NULL
polypeptide	NULL
.	NULL

Cell	NULL
64:961-968	NULL
.	NULL

Ohno	NULL
,	NULL
H.	NULL
,	NULL
G.	NULL
Takimoto	NULL
,	NULL
and	NULL
T.	NULL
W.	NULL
McKeithan	NULL
.	NULL

1990	NULL
.	NULL

The	NULL
candidate	NULL
proto-oncogene	NULL
be/-3	NULL
is	NULL
related	NULL
to	NULL
genes	NULL
implicated	NULL
in	NULL
cell	NULL
lineage	NULL
determination	NULL
and	NULL
cell	NULL
cycle	NULL
control	NULL
.	NULL

Cell	NULL
60:991-997.	NULL
.	NULL

Osame	NULL
,	NULL
M.	NULL
,	NULL
K.	NULL
Usuku	NULL
,	NULL
N.	NULL
Hichi	NULL
,	NULL
H.	NULL
Amitani	NULL
,	NULL
A.	NULL
Igata	NULL
,	NULL
M.	NULL
Matsumoto	NULL
,	NULL
and	NULL
H.	NULL
Tara	NULL
.	NULL

1986	NULL
.	NULL

HTLV-I	NULL
associated	NULL
myelopathy	NULL
,	NULL
a	NULL
new	NULL
clinical	NULL
entity	NULL
.	NULL

Lancet	NULL
i:1031-1032	NULL
.	NULL

Poiesz	NULL
,	NULL
B.	NULL
F.	NULL
,	NULL
F.	NULL
W.	NULL
Ruscetti	NULL
,	NULL
A.	NULL
F.	NULL
Gazdar	NULL
,	NULL
P.	NULL
A.	NULL
Bunn	NULL
,	NULL
J.	NULL
D.	NULL
Minna	NULL
,	NULL
and	NULL
R.	NULL
C.	NULL
Gallo	NULL
.	NULL

1980	NULL
.	NULL

Detection	NULL
and	NULL
isolation	NULL
of	NULL
a	NULL
type	NULL
C	NULL
retrovirus	NULL
particles	NULL
from	NULL
fresh	NULL
cultured	NULL
lymphocytes	NULL
of	NULL
a	NULL
patient	NULL
with	NULL
cutaneous	NULL
T-cell	NULL
lymphoma	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
77:7415-7419	NULL
.	NULL

Pozzatti	NULL
,	NULL
R.	NULL
,	NULL
J.	NULL
Vogel	NULL
,	NULL
and	NULL
G.	NULL
Jay	NULL
.	NULL

1990	NULL
.	NULL

The	NULL
human	NULL
T-lymphotropic	NULL
virus	NULL
type	NULL
I	NULL
tax	NULL
gene	NULL
can	NULL
cooperate	NULL
with	NULL
the	NULL
ras	NULL
oncogene	NULL
to	NULL
induce	NULL
neoplastic	NULL
transformation	NULL
of	NULL
cells	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

10:413-417	NULL
.	NULL

Rice	NULL
,	NULL
N.	NULL
R.	NULL
,	NULL
M.	NULL
L.	NULL
MacKichan	NULL
,	NULL
and	NULL
A.	NULL
Israel	NULL
.	NULL

1992	NULL
.	NULL

The	NULL
precursor	NULL
of	NULL
NF-kB	NULL
p50	NULL
has	NULL
IxB-like	NULL
functions	NULL
.	NULL

Cell	NULL
71:243-253.	NULL
.	NULL

Ruben	NULL
,	NULL
S.	NULL
,	NULL
H.	NULL
Poteat	NULL
,	NULL
T.	NULL
H.	NULL
Tan	NULL
,	NULL
K.	NULL
Kawakami	NULL
,	NULL
R.	NULL
Roeder	NULL
,	NULL
W.	NULL
Haseltine	NULL
,	NULL
and	NULL
C.	NULL
A.	NULL
Rosen	NULL
.	NULL

1988	NULL
.	NULL

Cellular	NULL
transcription	NULL
factors	NULL
and	NULL
regulation	NULL
of	NULL
the	NULL
IL-2	NULL
receptor	NULL
gene	NULL
expression	NULL
by	NULL
HTLV-I	NULL
tax	NULL
gene	NULL
product	NULL
.	NULL

Science	NULL
241:89-91	NULL
.	NULL

Ruben	NULL
,	NULL
S.	NULL
M.	NULL
,	NULL
P.	NULL
J.	NULL
Dillon	NULL
,	NULL
R.	NULL
Shcreck	NULL
,	NULL
T.	NULL
Henkel	NULL
,	NULL
C.-H.	NULL
Chen	NULL
,	NULL
M.	NULL
Maher	NULL
,	NULL
P.	NULL
A.	NULL
Baeuerie	NULL
,	NULL
and	NULL
C.	NULL
A.	NULL
Rosen	NULL
.	NULL

1991	NULL
.	NULL

Isolation	NULL
of	NULL
a	NULL
rel-related	NULL
human	NULL
cDNA	NULL
that	NULL
potentially	NULL
encodes	NULL
the	NULL
65-kD	NULL
subunit	NULL
of	NULL
NF-kB	NULL
.	NULL

Science	NULL
251:1490-1493	NULL
.	NULL

Ryseck	NULL
,	NULL
R.-P.	NULL
,	NULL
P.	NULL
Bull	NULL
,	NULL
M.	NULL
Takamiya	NULL
,	NULL
V.	NULL
Bours	NULL
,	NULL
U.	NULL
Siebenlist	NULL
,	NULL
P.	NULL
Dobrzanski	NULL
,	NULL
and	NULL
R.	NULL
Bravo	NULL
.	NULL

1992	NULL
.	NULL

RelB	NULL
,	NULL
a	NULL
new	NULL
Rel	NULL
family	NULL
transcription	NULL
activator	NULL
that	NULL
can	NULL
interact	NULL
with	NULL
p50-NF-kB	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

12:674-684	NULL
.	NULL

Sakashita	NULL
,	NULL
A.	NULL
,	NULL
T.	NULL
Hattori	NULL
,	NULL
C.	NULL
W.	NULL
Miller	NULL
,	NULL
H.	NULL
Suzushima	NULL
,	NULL
N.	NULL
Asou	NULL
,	NULL
K.	NULL
Takatsuki	NULL
,	NULL
and	NULL
H.	NULL
P.	NULL
Koeffier	NULL
.	NULL

1992	NULL
.	NULL

Mutations	NULL
of	NULL
the	NULL
p53	NULL
gene	NULL
in	NULL
adult	NULL
T-cell	NULL
leukemia	NULL
.	NULL

Blood	NULL
79:477-480	NULL
.	NULL

Schmid	NULL
,	NULL
R.	NULL
M.	NULL
,	NULL
N.	NULL
D.	NULL
Perkins	NULL
,	NULL
C.	NULL
S.	NULL
Duckett	NULL
,	NULL
P.	NULL
C.	NULL
Andrews	NULL
,	NULL
and	NULL
G.	NULL
J.	NULL
Nabel	NULL
.	NULL

1991	NULL
.	NULL

Cloning	NULL
of	NULL
an	NULL
NF-	NULL
«	NULL
B	NULL
subunit	NULL
which	NULL
stimulates	NULL
HIV	NULL
transcription	NULL
in	NULL
synergy	NULL
with	NULL
p65	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
352:733-736	NULL
.	NULL

Schmitz	NULL
,	NULL
M.	NULL
L.	NULL
,	NULL
and	NULL
P.	NULL
Baeuerle	NULL
.	NULL

1991	NULL
.	NULL

The	NULL
p65	NULL
subunit	NULL
is	NULL
responsible	NULL
for	NULL
the	NULL
strong	NULL
transcription	NULL
activating	NULL
potential	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

10:3805-3817	NULL
.	NULL

Sickevitz	NULL
,	NULL
M.	NULL
,	NULL
M.	NULL
B.	NULL
Feinberg	NULL
,	NULL
N.	NULL
Holbrook	NULL
,	NULL
F.	NULL
Wong-Staal	NULL
,	NULL
and	NULL
W.	NULL
C.	NULL
Greene	NULL
.	NULL

1987	NULL
.	NULL

Activation	NULL
of	NULL
interleukin	NULL
2	NULL
and	NULL
interleukin	NULL
2	NULL
receptor	NULL
(	NULL
Tac	NULL
)	NULL
promoter	NULL
expression	NULL
by	NULL
the	NULL
transactivator	NULL
(	NULL
tat	NULL
)	NULL
gene	NULL
product	NULL
of	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
I.	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
84:5389-5393	NULL
.	NULL

Smith	NULL
,	NULL
M.	NULL
R.	NULL
,	NULL
and	NULL
W.	NULL
C.	NULL
Greene	NULL
.	NULL

1990	NULL
.	NULL

Identification	NULL
of	NULL
HTLV-I	NULL
tax	NULL
trans-activator	NULL
mutants	NULL
exhibiting	NULL
novel	NULL
transcriptional	NULL
phe-notypes	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

4:1875-1885	NULL
.	NULL

Smith	NULL
,	NULL
M.	NULL
R.	NULL
,	NULL
and	NULL
W.	NULL
C.	NULL
Greene	NULL
.	NULL

1991	NULL
.	NULL

Molecular	NULL
biology	NULL
of	NULL
type	NULL
1	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
(	NULL
HTLV-I	NULL
)	NULL
and	NULL
adult	NULL
T-cell	NULL
leukemia	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

87:761-766	NULL
.	NULL

Smith	NULL
,	NULL
M.	NULL
R.	NULL
,	NULL
and	NULL
W.	NULL
C.	NULL
Greene	NULL
.	NULL

1991	NULL
.	NULL

Type	NULL
I	NULL
human	NULL
T-cell	NULL
74	NULL
.	NULL

75	NULL
.	NULL

76	NULL
.	NULL

77	NULL
.	NULL

78	NULL
.	NULL

79	NULL
.	NULL

80	NULL
.	NULL

81	NULL
.	NULL

82	NULL
.	NULL

83	NULL
.	NULL

84	NULL
.	NULL

85	NULL
.	NULL

86	NULL
.	NULL

87	NULL
.	NULL

88	NULL
.	NULL

89	NULL
.	NULL

Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

leukemia	NULL
virus	NULL
Tax	NULL
protein	NULL
transforms	NULL
rat	NULL
fibroblasts	NULL
through	NULL
the	NULL
cyclic	NULL
adenosine	NULL
monophosphate	NULL
response	NULL
element	NULL
binding	NULL
protein/activating	NULL
transcription	NULL
factor	NULL
pathway	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

88:1038-1042	NULL
.	NULL

Smith	NULL
,	NULL
M.	NULL
R.	NULL
,	NULL
and	NULL
W.	NULL
C.	NULL
Greene	NULL
.	NULL

1992	NULL
.	NULL

Characterization	NULL
of	NULL
a	NULL
novel	NULL
nuclear	NULL
localization	NULL
signal	NULL
in	NULL
the	NULL
HTLV-I	NULL
Tax	NULL
transactivator	NULL
protein	NULL
.	NULL

Virology	NULL
187:316-320	NULL
.	NULL

Sodroski	NULL
,	NULL
J.	NULL
,	NULL
C.	NULL
Rosen	NULL
,	NULL
W.	NULL
C.	NULL
Goh	NULL
,	NULL
and	NULL
W.	NULL
Haseltine	NULL
.	NULL

1985	NULL
.	NULL

A	NULL
transcriptional	NULL
activator	NULL
protein	NULL
encoded	NULL
by	NULL
the	NULL
x-lor	NULL
region	NULL
of	NULL
the	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
.	NULL

Science	NULL
228:1430-1434	NULL
.	NULL

Stein	NULL
,	NULL
B.	NULL
,	NULL
H.	NULL
Rahmsdorf	NULL
,	NULL
A.	NULL
Steffen	NULL
,	NULL
M.	NULL
Litfin	NULL
,	NULL
and	NULL
P.	NULL
Herrlich	NULL
.	NULL

1989	NULL
.	NULL

UV-induced	NULL
DNA	NULL
damage	NULL
is	NULL
an	NULL
intermediate	NULL
step	NULL
in	NULL
UV-induced	NULL
expression	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
,	NULL
collagenase	NULL
,	NULL
c-Fos	NULL
,	NULL
and	NULL
metallothionein	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

9:5169-5181	NULL
.	NULL

Stephens	NULL
,	NULL
R.	NULL
M.	NULL
,	NULL
N.	NULL
R.	NULL
Rice	NULL
,	NULL
R.	NULL
R.	NULL
Hiebsch	NULL
,	NULL
B.	NULL
H.	NULL
R.	NULL
,	NULL
and	NULL
R.	NULL
V.	NULL
Gilden	NULL
.	NULL

1983	NULL
.	NULL

Nucleotide	NULL
sequence	NULL
of	NULL
v-re/	NULL
:	NULL
the	NULL
oncogene	NULL
of	NULL
the	NULL
reticuloendotheliosis	NULL
virus	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
80	NULL
:	NULL
6229-6232	NULL
.	NULL

Steward	NULL
,	NULL
R.	NULL
1987	NULL
.	NULL

Dorsal	NULL
,	NULL
an	NULL
embryonic	NULL
polarity	NULL
gene	NULL
in	NULL
Drosophila	NULL
,	NULL
is	NULL
homologous	NULL
to	NULL
the	NULL
vertebrate	NULL
proto-oncogene	NULL
,	NULL
c-re/	NULL
.	NULL

Science	NULL
238:692-694	NULL
.	NULL

Sun	NULL
,	NULL
S.-C.	NULL
,	NULL
P.	NULL
A.	NULL
Ganchi	NULL
,	NULL
D.	NULL
W.	NULL
Ballard	NULL
,	NULL
and	NULL
W.	NULL
C.	NULL
Greene	NULL
.	NULL

1993	NULL
.	NULL

NF-	NULL
«	NULL
B	NULL
controls	NULL
expression	NULL
of	NULL
inhibitor	NULL
IxBa	NULL
:	NULL
evidence	NULL
for	NULL
an	NULL
inducible	NULL
autoregulatory	NULL
pathway	NULL
.	NULL

Science	NULL
259:1912-1915	NULL
.	NULL

Sun	NULL
,	NULL
S.	NULL
C.	NULL
,	NULL
P.	NULL
Ganchi	NULL
,	NULL
C.	NULL
Béraud	NULL
,	NULL
D.	NULL
W.	NULL
Ballard	NULL
,	NULL
and	NULL
W.	NULL
C.	NULL
Greene	NULL
.	NULL

Autoregulation	NULL
of	NULL
the	NULL
NF-kB	NULL
p65	NULL
transactivator	NULL
by	NULL
multiple	NULL
cytoplasmic	NULL
inhibitors	NULL
containing	NULL
ankyrin	NULL
motifs	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
in	NULL
press	NULL
.	NULL

Suzuki	NULL
,	NULL
T.	NULL
,	NULL
J.	NULL
I.	NULL
Fujisawa	NULL
,	NULL
M.	NULL
Toita	NULL
,	NULL
and	NULL
M.	NULL
Yoshida	NULL
.	NULL

1993	NULL
.	NULL

The	NULL
trans-activator	NULL
tax	NULL
of	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
1	NULL
(	NULL
HTLV-I	NULL
)	NULL
interacts	NULL
with	NULL
cAMP-responsive	NULL
element	NULL
(	NULL
CRE	NULL
)	NULL
binding	NULL
and	NULL
CRE	NULL
modulator	NULL
proteins	NULL
that	NULL
bind	NULL
to	NULL
the	NULL
21-base-pair	NULL
enhancer	NULL
of	NULL
HTLV-I	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
90:610-614	NULL
.	NULL

Tanaka	NULL
,	NULL
A.	NULL
,	NULL
C.	NULL
Takahashi	NULL
,	NULL
S.	NULL
Yamaoka	NULL
,	NULL
T.	NULL
Nosaka	NULL
,	NULL
M.	NULL
Maki	NULL
,	NULL
and	NULL
M.	NULL
Hatanaka	NULL
.	NULL

1990	NULL
.	NULL

Oncogenic	NULL
transformation	NULL
by	NULL
the	NULL
tax	NULL
gene	NULL
of	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
I	NULL
in	NULL
vitro	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
87:1071-1075	NULL
.	NULL

Uchiyama	NULL
,	NULL
T.	NULL
,	NULL
J.	NULL
Yodoi	NULL
,	NULL
K.	NULL
Sagawa	NULL
,	NULL
K.	NULL
Takatsuki	NULL
,	NULL
and	NULL
H.	NULL
Uchino	NULL
.	NULL

1977	NULL
.	NULL

Adult	NULL
T-cell	NULL
leukemia	NULL
:	NULL
clinical	NULL
and	NULL
hematologic	NULL
features	NULL
of	NULL
16	NULL
cases	NULL
.	NULL

Blood	NULL
50:481-492	NULL
.	NULL

Urban	NULL
,	NULL
M.	NULL
B.	NULL
,	NULL
and	NULL
P.	NULL
A.	NULL
Baeuerle	NULL
.	NULL

1990	NULL
.	NULL

The	NULL
65-kD	NULL
subunit	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
is	NULL
a	NULL
receptor	NULL
for	NULL
IxB	NULL
and	NULL
a	NULL
modulator	NULL
of	NULL
DNA-binding	NULL
specificity	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

4:1975-1984	NULL
.	NULL

Wilhelmsen	NULL
,	NULL
K.	NULL
C.	NULL
,	NULL
K.	NULL
Eggleton	NULL
,	NULL
and	NULL
H.	NULL
M.	NULL
Temin	NULL
.	NULL

1984	NULL
.	NULL

Nucleic	NULL
acid	NULL
sequence	NULL
of	NULL
the	NULL
oncogene	NULL
v-re	NULL
!	NULL

in	NULL
reticuloendotheliosis	NULL
virus	NULL
strain	NULL
T	NULL
and	NULL
its	NULL
cellular	NULL
homolog	NULL
,	NULL
the	NULL
protooncogene	NULL
c-rel	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

52:172-182	NULL
.	NULL

Wulezyn	NULL
,	NULL
F.	NULL
G.	NULL
,	NULL
M.	NULL
Naumann	NULL
,	NULL
and	NULL
C.	NULL
Scheidereit	NULL
.	NULL

1992	NULL
.	NULL

Candidate	NULL
proto-oncogene	NULL
be/-3	NULL
encodes	NULL
a	NULL
subunit-specific	NULL
inhibitor	NULL
of	NULL
transcription	NULL
factor	NULL
NF-kB	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
358:597-599	NULL
.	NULL

Yoshida	NULL
,	NULL
M.	NULL
,	NULL
I.	NULL
Miyoshi	NULL
,	NULL
and	NULL
Y.	NULL
Hinuma	NULL
.	NULL

1982	NULL
.	NULL

Isolation	NULL
and	NULL
characterization	NULL
of	NULL
retrovirus	NULL
from	NULL
cell	NULL
lines	NULL
of	NULL
human	NULL
adult	NULL
T-cell	NULL
leukemia	NULL
and	NULL
its	NULL
implication	NULL
in	NULL
the	NULL
disease	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
79:2031-2035	NULL
.	NULL

Zabel	NULL
,	NULL
U.	NULL
,	NULL
and	NULL
P.	NULL
A.	NULL
Baeuerle	NULL
.	NULL

1990	NULL
.	NULL

Purified	NULL
human	NULL
IB	NULL
can	NULL
rapidly	NULL
dissociate	NULL
the	NULL
complex	NULL
of	NULL
the	NULL
NF-KB	NULL
transcription	NULL
factor	NULL
with	NULL
its	NULL
cognate	NULL
DNA	NULL
.	NULL

Cell	NULL
61:255-265	NULL
.	NULL

Zhao	NULL
,	NULL
L.	NULL
J.	NULL
,	NULL
and	NULL
C.	NULL
Z.	NULL
Giam	NULL
.	NULL

1991	NULL
.	NULL

Interaction	NULL
of	NULL
T-cell	NULL
lymphotropic	NULL
virus	NULL
type	NULL
I	NULL
(	NULL
HTLV-I	NULL
)	NULL
transcriptional	NULL
activator	NULL
Tax	NULL
with	NULL
cellular	NULL
factors	NULL
that	NULL
bind	NULL
specifically	NULL
to	NULL
the	NULL
21-base-pair	NULL
repeats	NULL
in	NULL
the	NULL
HTLV-I	NULL
enhancer	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

88:11445-11449.	NULL
.	NULL

Zhao	NULL
,	NULL
L.	NULL
J.	NULL
,	NULL
and	NULL
C.	NULL
Z.	NULL
Giam	NULL
.	NULL

1992	NULL
.	NULL

Human	NULL
T-cell	NULL
lymphotropic	NULL
virus	NULL
type	NULL
I	NULL
(	NULL
HTLV-I	NULL
)	NULL
transcriptional	NULL
activator	NULL
,	NULL
Tax	NULL
,	NULL
enhances	NULL
CREB	NULL
binding	NULL
to	NULL
HTLV-I	NULL
21-base-pair	NULL
repeats	NULL
by	NULL
protein-protein	NULL
interaction	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
89:7070-7074	NULL
.	NULL

